Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 415 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ABCC9 CL E G H | 10060 | 60 | OMIM:619719 | INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS | | | | 254 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ABL1 CL E G H | 25 | 76 | OMIM:617602 | Congenital heart defects and skeletal malformations syndrome | | | | 51 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | | | | 16 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACTA2 CL E G H | 59 | 130 | OMIM:611788 | AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6 | | | | 94 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACTA2 CL E G H | 59 | 130 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 94 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACTA2 CL E G H | 59 | 130 | ORPHA:2573 | Moyamoya disease | | | | 94 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 178 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADA2 CL E G H | 51816 | 1839 | ORPHA:820 | Sneddon syndrome | HP:0040281 - Very frequent | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADAM17 CL E G H | 6868 | 195 | OMIM:614328 | INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADAM17 CL E G H | 6868 | 195 | ORPHA:294023 | Neonatal inflammatory skin and bowel disease | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADAMTS2 CL E G H | 9509 | 218 | OMIM:225410 | Ehlers-Danlos syndrome, type VII, autosomal recessive | | | | 165 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 116 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ADGRE2 CL E G H | 30817 | 3337 | OMIM:125630 | Dermodistortive urticaria | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AEBP1 CL E G H | 165 | 303 | OMIM:618000 | Ehlers-Danlos syndrome, classic-like, 2 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AGA CL E G H | 175 | 318 | OMIM:208400 | ASPARTYLGLUCOSAMINURIA | | | | 76 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AGA CL E G H | 175 | 318 | ORPHA:93 | Aspartylglucosaminuria | HP:0040283 - Occasional | | | 76 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 85 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AGXT CL E G H | 189 | 341 | OMIM:259900 | Hyperoxaluria, primary, type I | | | | 260 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:201 | Cowden syndrome | | | | 54 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:744 | Proteus syndrome | HP:0040281 - Very frequent | | | 54 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AKT3 CL E G H | 10000 | 393 | OMIM:615937 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 2 | | | | 19 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALDH18A1 CL E G H | 5832 | 9722 | OMIM:219150 | Cutis laxa, autosomal recessive, type IIIA | | | | 89 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALDH3A2 CL E G H | 224 | 403 | ORPHA:816 | Sjögren-Larsson syndrome | | | | 87 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALOX12B CL E G H | 242 | 430 | OMIM:242100 | Ichthyosis, congenital, autosomal recessive 2 | | | | 75 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALOXE3 CL E G H | 59344 | 13743 | OMIM:242100 | Ichthyosis, congenital, autosomal recessive 2 | | | | 63 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALOXE3 CL E G H | 59344 | 13743 | OMIM:606545 | Ichthyosis, congenital, autosomal recessive 3 | | | | 63 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ALPK1 CL E G H | 80216 | 20917 | OMIM:614979 | Splenomegaly, cytopenia, and vision loss | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ANAPC1 CL E G H | 64682 | 19988 | ORPHA:221008 | Rothmund-Thomson syndrome type 1 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ANGPT1 CL E G H | 284 | 484 | OMIM:619361 | ANGIOEDEMA, HEREDITARY, 5; HAE5 | | | | 5 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ANKRD26 CL E G H | 22852 | 29186 | OMIM:188000 | THROMBOCYTOPENIA 2; THC2 | | | | 106 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ANTXR1 CL E G H | 84168 | 21014 | OMIM:230740 | Gapo syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | | | | 49 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AP1S1 CL E G H | 1174 | 559 | OMIM:609313 | Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | AQP5 CL E G H | 362 | 638 | ORPHA:2337 | Non-epidermolytic palmoplantar keratoderma | | | | 5 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | | | | 147 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARHGAP31 CL E G H | 57514 | 29216 | OMIM:100300 | Adams-Oliver syndrome 1 | | | | 147 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARID1B CL E G H | 57492 | 18040 | OMIM:135900 | Coffin-Siris syndrome 1 | | | | 219 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARPC1B CL E G H | 10095 | 704 | OMIM:617718 | Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARPC4 CL E G H | 10093 | 707 | OMIM:620141 | | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ARX CL E G H | 170302 | 18060 | ORPHA:94083 | Partington syndrome | | | | 166 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ASXL1 CL E G H | 171023 | 18318 | ORPHA:98850 | Aggressive systemic mastocytosis | | | | 145 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ASXL1 CL E G H | 171023 | 18318 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | | | | 145 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATM CL E G H | 472 | 795 | ORPHA:100 | Ataxia-telangiectasia | | | | 3267 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | | | | 3267 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP2C1 CL E G H | 27032 | 13211 | OMIM:169600 | Benign chronic pemphigus | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP2C1 CL E G H | 27032 | 13211 | ORPHA:2841 | Familial benign chronic pemphigus | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP6 CL E G H | 4508 | 7414 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 140 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:2834 | Wrinkly skin syndrome | | | | 140 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP7A CL E G H | 538 | 869 | ORPHA:565 | Menkes disease | | | | 192 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP7A CL E G H | 538 | 869 | ORPHA:198 | Occipital horn syndrome | | | | 192 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP7A CL E G H | 538 | 869 | OMIM:304150 | Occipital horn syndrome | | | | 192 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | | | | 315 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATR CL E G H | 545 | 882 | OMIM:614564 | Cutaneous telangiectasia and cancer syndrome, familial | | | | 168 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATRX CL E G H | 546 | 886 | ORPHA:231401 | Alpha-thalassemia-myelodysplastic syndrome | | | | 169 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | 169 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | | | | 38 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BANF1 CL E G H | 8815 | 17397 | OMIM:614008 | Nestor-Guillermo progeria syndrome | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | | | | 101 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BLM CL E G H | 641 | 1058 | ORPHA:125 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BLOC1S3 CL E G H | 388552 | 20914 | OMIM:614077 | Hermansky-Pudlak syndrome 8 | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BMP2 CL E G H | 650 | 1069 | OMIM:235200 | Hemochromatosis, type 1 | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BMPR2 CL E G H | 659 | 1078 | OMIM:178600 | Pulmonary hypertension, primary, 1 | | | | 525 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BRAF CL E G H | 673 | 1097 | OMIM:163950 | Noonan syndrome 1 | | | | 276 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BRD4 CL E G H | 23476 | 13575 | ORPHA:199 | Cornelia de Lange syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 105 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | C1R CL E G H | 715 | 1246 | OMIM:130080 | Ehlers-Danlos syndrome, periodontal type, 1 | | | | 15 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | C1S CL E G H | 716 | 1247 | OMIM:617174 | Ehlers-Danlos syndrome, periodontal type, 2 | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | C2 CL E G H | 717 | 1248 | OMIM:217000 | Complement component 2 deficiency | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | C4A CL E G H | 720 | 1323 | OMIM:614380 | Complement component 4A deficiency | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CALR CL E G H | 811 | 1455 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CARMIL2 CL E G H | 146206 | 27089 | OMIM:618131 | IMMUNODEFICIENCY 58; IMD58 | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 87 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CASZ1 CL E G H | 54897 | 26002 | ORPHA:1606 | 1p36 deletion syndrome | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 48 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CBL CL E G H | 867 | 1541 | ORPHA:98850 | Aggressive systemic mastocytosis | | | | 317 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CBS CL E G H | 875 | 1550 | ORPHA:394 | Classic homocystinuria | | | | 242 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CBS CL E G H | 875 | 1550 | OMIM:236200 | Homocystinuria due to cystathionine beta-synthase deficiency | | | | 242 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCM2 CL E G H | 83605 | 21708 | OMIM:603284 | Cerebral cavernous malformations-2 | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCM2 CL E G H | 83605 | 21708 | ORPHA:221061 | Familial cerebral cavernous malformation | HP:0040283 - Occasional | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | | | | 38 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CD81 CL E G H | 975 | 1701 | OMIM:613496 | Immunodeficiency, common variable, 6 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | | | | 102 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CHST14 CL E G H | 113189 | 24464 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | | | | 27 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CIB1 CL E G H | 10519 | 16920 | ORPHA:302 | Epidermodysplasia verruciformis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 102 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CLEC7A CL E G H | 64581 | 14558 | ORPHA:1334 | Chronic mucocutaneous candidiasis | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COG4 CL E G H | 25839 | 18620 | OMIM:618150 | Saul-Wilson syndrome | | | | 67 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COG8 CL E G H | 84342 | 18623 | ORPHA:95428 | COG8-CDG | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A1 CL E G H | 1277 | 2197 | OMIM:619115 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1 | | | | 373 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:31112 | Dermatofibrosarcoma protuberans | | | | 373 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A1 CL E G H | 1277 | 2197 | OMIM:130060 | Ehlers-Danlos syndrome, arthrochalasia type, 1 | | | | 373 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A1 CL E G H | 1277 | 2197 | OMIM:166200 | Osteogenesis imperfecta, type I | | | | 373 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A2 CL E G H | 1278 | 2198 | ORPHA:230851 | Cardiac-valvular Ehlers-Danlos syndrome | | | | 243 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A2 CL E G H | 1278 | 2198 | OMIM:619120 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2 | | | | 243 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A2 CL E G H | 1278 | 2198 | OMIM:617821 | Ehlers-Danlos syndrome, arthrochalasia type, 2 | | | | 243 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL1A2 CL E G H | 1278 | 2198 | OMIM:225320 | Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form | | | | 243 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:2500 | Acrogeria | | | | 749 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL3A1 CL E G H | 1281 | 2201 | OMIM:618343 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | | | | 749 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | | | | 749 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:158673 | Localized dystrophic epidermolysis bullosa, acral form | | | | 263 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | COX7B CL E G H | 1349 | 2291 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CPN1 CL E G H | 1369 | 2312 | OMIM:212070 | Carboxypeptidase N deficiency | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CREB3L1 CL E G H | 90993 | 18856 | OMIM:616229 | Osteogenesis imperfecta, type XVI | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CSTA CL E G H | 1475 | 2481 | ORPHA:263534 | Acral peeling skin syndrome | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTC1 CL E G H | 80169 | 26169 | OMIM:612199 | Cerebroretinal microangiopathy with calcifications and cysts | | | | 160 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTC1 CL E G H | 80169 | 26169 | ORPHA:1775 | Dyskeratosis congenita | | | | 160 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTSA CL E G H | 5476 | 9251 | OMIM:256540 | Galactosialidosis | | | | 51 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTSB CL E G H | 1508 | 2527 | ORPHA:50943 | Keratolytic winter erythema | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CTSB CL E G H | 1508 | 2527 | OMIM:148370 | Keratolytic winter erythema | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CYLD CL E G H | 1540 | 2584 | ORPHA:211 | Familial cylindromatosis | | | | 126 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CYLD CL E G H | 1540 | 2584 | ORPHA:867 | Familial multiple trichoepithelioma | | | | 126 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | CYTB CL E G H | 4519 | 7427 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | | | | 30 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DDB2 CL E G H | 1643 | 2718 | OMIM:278740 | Xeroderma pigmentosum, complementation group E | | | | 30 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DDR2 CL E G H | 4921 | 2731 | OMIM:618175 | WARBURG-CINOTTI SYNDROME; WRCN | | | | 45 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DDX11 CL E G H | 1663 | 2736 | OMIM:613398 | Warsaw breakage syndrome | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DHCR7 CL E G H | 1717 | 2860 | ORPHA:818 | Smith-Lemli-Opitz syndrome | | | | 159 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DIAPH1 CL E G H | 1729 | 2876 | ORPHA:2573 | Moyamoya disease | | | | 118 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DKC1 CL E G H | 1736 | 2890 | ORPHA:1775 | Dyskeratosis congenita | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DLL4 CL E G H | 54567 | 2910 | ORPHA:974 | Adams-Oliver syndrome | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DLL4 CL E G H | 54567 | 2910 | OMIM:616589 | Adams-Oliver syndrome 6 | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DNAJC30 CL E G H | 84277 | 16410 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DNAJC30 CL E G H | 84277 | 16410 | OMIM:619382 | LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DNASE1L3 CL E G H | 1776 | 2959 | ORPHA:36412 | Hypocomplementemic urticarial vasculitis | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DOCK6 CL E G H | 57572 | 19189 | ORPHA:974 | Adams-Oliver syndrome | | | | 18 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DOCK6 CL E G H | 57572 | 19189 | OMIM:614219 | Adams-Oliver syndrome 2 | | | | 18 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DPM1 CL E G H | 8813 | 3005 | OMIM:608799 | Congenital disorder of glycosylation, type IE | | | | 27 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DSE CL E G H | 29940 | 21144 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DSG4 CL E G H | 147409 | 21307 | OMIM:607903 | Hypotrichosis 6 | | | | 63 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DSP CL E G H | 1832 | 3052 | OMIM:615821 | Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis | | | | 747 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DSP CL E G H | 1832 | 3052 | OMIM:607655 | Skin fragility-woolly hair syndrome | | | | 747 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DST CL E G H | 667 | 1090 | OMIM:614653 | Neuropathy, hereditary sensory and autonomic, type VI | | | | 108 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | DTNBP1 CL E G H | 84062 | 17328 | OMIM:614076 | Hermansky-Pudlak syndrome 7 | | | | 46 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EGFR CL E G H | 1956 | 3236 | ORPHA:294023 | Neonatal inflammatory skin and bowel disease | | | | 257 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ELMO2 CL E G H | 63916 | 17233 | ORPHA:3019 | Ramon syndrome | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ELN CL E G H | 2006 | 3327 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 172 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ELOVL4 CL E G H | 6785 | 14415 | OMIM:614457 | Ichthyosis, spastic quadriplegia, and mental retardation | | | | 62 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ELOVL4 CL E G H | 6785 | 14415 | ORPHA:1955 | Spinocerebellar ataxia type 34 | | | | 62 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EMILIN1 CL E G H | 11117 | 19880 | OMIM:620080 | | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 186 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 151 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EOGT CL E G H | 285203 | 28526 | ORPHA:974 | Adams-Oliver syndrome | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EOGT CL E G H | 285203 | 28526 | OMIM:615297 | Adams-Oliver syndrome 4 | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EPHB2 CL E G H | 2048 | 3393 | OMIM:618462 | Bleeding disorder, platelet-type, 22 | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EPHB4 CL E G H | 2050 | 3395 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | EPHB4 CL E G H | 2050 | 3395 | OMIM:618196 | Capillary malformation-arteriovenous malformation 2 | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:601675 | Trichothiodystrophy 1, photosensitive | | | | 106 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | | | | 106 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:278730 | Xeroderma pigmentosum, complementation group D | | | | 106 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 106 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | | | | 54 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 54 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | | | | 158 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC4 CL E G H | 2072 | 3436 | OMIM:278760 | Xeroderma pigmentosum, complementation group F | | | | 158 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 158 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | | | | 83 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 83 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | | | | 199 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:600630 | Uv-Sensitive syndrome 1 | | | | 199 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F10 CL E G H | 2159 | 3528 | ORPHA:328 | Congenital factor X deficiency | | | | 33 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F12 CL E G H | 2161 | 3530 | OMIM:610618 | ANGIOEDEMA, HEREDITARY, TYPE III; HAE3 | | | | 28 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | | | | 60 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F5 CL E G H | 2153 | 3542 | ORPHA:326 | Congenital factor V deficiency | | | | 159 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F5 CL E G H | 2153 | 3542 | OMIM:227400 | Factor V deficiency | | | | 159 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F7 CL E G H | 2155 | 3544 | ORPHA:327 | Congenital factor VII deficiency | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F8 CL E G H | 2157 | 3546 | ORPHA:177926 | Bleeding disorder in hemophilia A carriers without FVIII deficiency | | | | 303 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F8 CL E G H | 2157 | 3546 | OMIM:306700 | Hemophilia A | | | | 303 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F8 CL E G H | 2157 | 3546 | ORPHA:169805 | Moderate hemophilia A | | | | 303 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | F8 CL E G H | 2157 | 3546 | ORPHA:169802 | Severe hemophilia A | | | | 303 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FANCA CL E G H | 2175 | 3582 | OMIM:227650 | Fanconi anemia | | | | 340 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FANCC CL E G H | 2176 | 3584 | OMIM:227645 | Fanconi anemia, complementation group C | | | | 410 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | | | | 147 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FANCE CL E G H | 2178 | 3586 | OMIM:600901 | Fanconi anemia, complementation group E | | | | 73 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 59 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FAS CL E G H | 355 | 11920 | OMIM:601859 | Autoimmune lymphoproliferative syndrome | | | | 59 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FASLG CL E G H | 356 | 11936 | OMIM:601859 | Autoimmune lymphoproliferative syndrome | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FBN1 CL E G H | 2200 | 3603 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 1361 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FBN1 CL E G H | 2200 | 3603 | OMIM:616914 | Marfan lipodystrophy syndrome | | | | 1361 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FECH CL E G H | 2235 | 3647 | ORPHA:79278 | Autosomal erythropoietic protoporphyria | | | | 145 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FECH CL E G H | 2235 | 3647 | OMIM:177000 | Protoporphyria, erythropoietic, 1 | | | | 145 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FERMT1 CL E G H | 55612 | 15889 | ORPHA:2908 | Kindler epidermolysis bullosa | | | | 136 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FERMT1 CL E G H | 55612 | 15889 | OMIM:173650 | Kindler syndrome | | | | 136 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FGA CL E G H | 2243 | 3661 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 47 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FGB CL E G H | 2244 | 3662 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 62 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FGG CL E G H | 2266 | 3694 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FKBP14 CL E G H | 55033 | 18625 | OMIM:614557 | Ehlers-Danlos syndrome, kyphoscoliotic type, 2 | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FKBP14 CL E G H | 55033 | 18625 | ORPHA:300179 | Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FLNA CL E G H | 2316 | 3754 | ORPHA:75497 | X-linked Ehlers-Danlos syndrome | | | | 493 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FLT4 CL E G H | 2324 | 3767 | OMIM:153100 | Lymphatic malformation 1 | | | | 90 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FOXE3 CL E G H | 2301 | 3808 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FOXP3 CL E G H | 50943 | 6106 | ORPHA:37042 | Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FRG1 CL E G H | 2483 | 3954 | OMIM:158900 | Facioscapulohumeral muscular dystrophy 1 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FTO CL E G H | 79068 | 24678 | OMIM:612938 | Growth retardation, developmental delay, coarse facies, and earlydeath | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FUCA1 CL E G H | 2517 | 4006 | OMIM:230000 | FUCOSIDOSIS | | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FUCA1 CL E G H | 2517 | 4006 | ORPHA:349 | Fucosidosis | HP:0040282 - Frequent | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | FZD4 CL E G H | 8322 | 4042 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 109 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | G6PC3 CL E G H | 92579 | 24861 | OMIM:612541 | Neutropenia, severe congenital, 4, autosomal recessive | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GABRD CL E G H | 2563 | 4084 | ORPHA:1606 | 1p36 deletion syndrome | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GATA2 CL E G H | 2624 | 4171 | ORPHA:3226 | Deafness-lymphedema-leukemia syndrome | | | | 137 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:77259 | Gaucher disease type 1 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GDF2 CL E G H | 2658 | 4217 | OMIM:615506 | TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5 | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA1 CL E G H | 2697 | 4274 | ORPHA:1010 | Autosomal dominant palmoplantar keratoderma and congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA1 CL E G H | 2697 | 4274 | ORPHA:317 | Erythrokeratodermia variabilis | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA1 CL E G H | 2697 | 4274 | OMIM:617525 | Erythrokeratodermia variabilis et progressiva 3 | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA1 CL E G H | 2697 | 4274 | OMIM:104100 | Palmoplantar keratoderma with congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA5 CL E G H | 2702 | 4279 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJA8 CL E G H | 2703 | 4281 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJB3 CL E G H | 2707 | 4285 | ORPHA:317 | Erythrokeratodermia variabilis | | | | 74 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJB4 CL E G H | 127534 | 4286 | ORPHA:317 | Erythrokeratodermia variabilis | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GJB4 CL E G H | 127534 | 4286 | OMIM:617524 | Erythrokeratodermia variabilis et progressiva 2 | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | | | | 291 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GLA CL E G H | 2717 | 4296 | OMIM:301500 | Fabry disease | | | | 291 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GLB1 CL E G H | 2720 | 4298 | OMIM:230500 | GM1-gangliosidosis, type I | | | | 120 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | | | | 16 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | | | | 240 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GSN CL E G H | 2934 | 4620 | ORPHA:85448 | AGel amyloidosis | | | | 53 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GUCY1A1 CL E G H | 2982 | 4685 | OMIM:615750 | Moyamoya disease 6 with achalasia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | GUCY1A1 CL E G H | 2982 | 4685 | ORPHA:401945 | Moyamoya disease with early-onset achalasia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | H4C3 CL E G H | 8364 | 4787 | OMIM:619758 | TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HBA1 CL E G H | 3039 | 4823 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 200 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HBA2 CL E G H | 3040 | 4824 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HCCS CL E G H | 3052 | 4837 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HDAC8 CL E G H | 55869 | 13315 | ORPHA:199 | Cornelia de Lange syndrome | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HDAC8 CL E G H | 55869 | 13315 | OMIM:300882 | Cornelia de Lange syndrome 5 | | | | 37 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HEATR3 CL E G H | 55027 | 26087 | OMIM:620072 | | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HEY2 CL E G H | 23493 | 4881 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HFE CL E G H | 3077 | 4886 | OMIM:235200 | Hemochromatosis, type 1 | | | | 38 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:36426 | Stevens-Johnson syndrome | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:703 | Bullous pemphigoid | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:703 | Bullous pemphigoid | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPGD CL E G H | 3248 | 5154 | OMIM:259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive 1 | | | | 55 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPS3 CL E G H | 84343 | 15597 | OMIM:614072 | Hermansky-Pudlak syndrome 3 | | | | 67 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | | | | 123 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | | | | 105 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HS3ST6 CL E G H | 64711 | 14178 | OMIM:619367 | ANGIOEDEMA, HEREDITARY, 8; HAE8 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1606 | 1p36 deletion syndrome | | | | 345 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IARS2 CL E G H | 55699 | 29685 | OMIM:616007 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia | | | | 25 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 28 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IFIH1 CL E G H | 64135 | 18873 | OMIM:615846 | Aicardi-Goutieres syndrome 7 | | | | 28 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IKBKG CL E G H | 8517 | 5961 | OMIM:308300 | Incontinentia pigmenti | | | | 52 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IKBKG CL E G H | 8517 | 5961 | ORPHA:464 | Incontinentia pigmenti | | | | 52 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IKZF1 CL E G H | 10320 | 13176 | ORPHA:36426 | Stevens-Johnson syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:319552 | Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency | | | | 46 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | | | | 46 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL17F CL E G H | 112744 | 16404 | ORPHA:1334 | Chronic mucocutaneous candidiasis | | | | 14 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL17RA CL E G H | 23765 | 5985 | ORPHA:1334 | Chronic mucocutaneous candidiasis | | | | 196 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL17RC CL E G H | 84818 | 18358 | ORPHA:1334 | Chronic mucocutaneous candidiasis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL36RN CL E G H | 26525 | 15561 | OMIM:614204 | PSORIASIS 14, PUSTULAR; PSORS14 | | | | 51 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IL7 CL E G H | 3574 | 6023 | ORPHA:302 | Epidermodysplasia verruciformis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IPO8 CL E G H | 10526 | 9853 | ORPHA:60030 | Loeys-Dietz syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IPO8 CL E G H | 10526 | 9853 | OMIM:619472 | VISS syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 119 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 69 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGA3 CL E G H | 3675 | 6139 | OMIM:614748 | Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 80 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | | | | 80 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | JAK2 CL E G H | 3717 | 6192 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 57 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | JAK2 CL E G H | 3717 | 6192 | ORPHA:729 | Polycythemia vera | | | | 57 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | | | | 57 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | JAM2 CL E G H | 58494 | 14686 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KCNAB2 CL E G H | 8514 | 6229 | ORPHA:1606 | 1p36 deletion syndrome | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KCNQ2 CL E G H | 3785 | 6296 | ORPHA:439218 | KCNQ2-related epileptic encephalopathy | | | | 528 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KDSR CL E G H | 2531 | 4021 | ORPHA:317 | Erythrokeratodermia variabilis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KDSR CL E G H | 2531 | 4021 | OMIM:617526 | Erythrokeratodermia variabilis et progressiva 4 | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KDSR CL E G H | 2531 | 4021 | ORPHA:316 | Progressive symmetric erythrokeratodermia | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIAA0319L CL E G H | 79932 | 30071 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIT CL E G H | 3815 | 6342 | ORPHA:280785 | Bullous diffuse cutaneous mastocytosis | | | | 327 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIT CL E G H | 3815 | 6342 | OMIM:606764 | Gastrointestinal stromal tumor | | | | 327 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIT CL E G H | 3815 | 6342 | OMIM:154800 | Mastocytosis, cutaneous | | | | 327 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KIT CL E G H | 3815 | 6342 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | | | | 327 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KLLN CL E G H | 100144748 | 37212 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KNG1 CL E G H | 3827 | 6383 | OMIM:619363 | ANGIOEDEMA, HEREDITARY, 6; HAE6 | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRAS CL E G H | 3845 | 6407 | OMIM:609942 | Noonan syndrome 3 | | | | 196 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRIT1 CL E G H | 889 | 1573 | ORPHA:221061 | Familial cerebral cavernous malformation | HP:0040283 - Occasional | | | 92 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT1 CL E G H | 3848 | 6412 | ORPHA:530838 | KRT1-related diffuse nonepidermolytic keratoderma | | | | 100 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT10 CL E G H | 3858 | 6413 | OMIM:607602 | Ichthyosis, cyclic, with epidermolytic hyperkeratosis | | | | 45 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT14 CL E G H | 3861 | 6416 | ORPHA:79396 | Autosomal dominant generalized epidermolysis bullosa simplex, severe form | | | | 110 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT2 CL E G H | 3849 | 6439 | ORPHA:455 | Superficial epidermolytic ichthyosis | | | | 67 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT5 CL E G H | 3852 | 6442 | ORPHA:79396 | Autosomal dominant generalized epidermolysis bullosa simplex, severe form | | | | 173 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT5 CL E G H | 3852 | 6442 | ORPHA:158681 | Epidermolysis bullosa simplex with circinate migratory erythema | | | | 173 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT5 CL E G H | 3852 | 6442 | OMIM:609352 | EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA | | | | 173 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | KRT83 CL E G H | 3889 | 6460 | ORPHA:316 | Progressive symmetric erythrokeratodermia | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LARP7 CL E G H | 51574 | 24912 | ORPHA:319671 | Alazami syndrome | | | | 16 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LBR CL E G H | 3930 | 6518 | ORPHA:779 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LEMD2 CL E G H | 221496 | 21244 | OMIM:619322 | MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LIG1 CL E G H | 3978 | 6598 | OMIM:619774 | IMMUNODEFICIENCY 96; IMD96 | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:99812 | LIG4 syndrome | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LIG4 CL E G H | 3981 | 6601 | OMIM:606593 | Lig4 syndrome | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LIPN CL E G H | 643418 | 23452 | OMIM:613943 | Ichthyosis, congenital, autosomal recessive 8 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LMAN1 CL E G H | 3998 | 6631 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | | | | 645 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LMNA CL E G H | 4000 | 6636 | ORPHA:740 | Hutchinson-Gilford progeria syndrome | | | | 645 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LMNA CL E G H | 4000 | 6636 | OMIM:151660 | Lipodystrophy, familial partial, type 2 | | | | 645 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LMX1B CL E G H | 4010 | 6654 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | | | | 165 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LORICRIN CL E G H | 4014 | 6663 | ORPHA:316 | Progressive symmetric erythrokeratodermia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LOX CL E G H | 4015 | 6664 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LRP1 CL E G H | 4035 | 6692 | ORPHA:79100 | Atrophoderma vermiculata | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LRP1 CL E G H | 4035 | 6692 | OMIM:604093 | Keratosis pilaris atrophicans | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LRP5 CL E G H | 4041 | 6697 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 125 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LUZP1 CL E G H | 7798 | 14985 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LYST CL E G H | 1130 | 1968 | ORPHA:352723 | Attenuated Chédiak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LYST CL E G H | 1130 | 1968 | ORPHA:167 | Chédiak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | LYST CL E G H | 1130 | 1968 | OMIM:214500 | Chediak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MANBA CL E G H | 4126 | 6831 | OMIM:248510 | MANNOSIDOSIS, BETA A, LYSOSOMAL | | | | 55 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MAP2K1 CL E G H | 5604 | 6840 | OMIM:163950 | Noonan syndrome 1 | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MAPK1 CL E G H | 5594 | 6871 | OMIM:619087 | NOONAN SYNDROME 13; NS13 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MASP1 CL E G H | 5648 | 6901 | OMIM:257920 | 3mc syndrome 1 | | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MAT2A CL E G H | 4144 | 6904 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:2273 | Ichthyosis follicularis-alopecia-photophobia syndrome | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MBTPS2 CL E G H | 51360 | 15455 | OMIM:308800 | Keratosis follicularis spinulosa decalvans, X-linked | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MCFD2 CL E G H | 90411 | 18451 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 77 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MEFV CL E G H | 4210 | 6998 | ORPHA:342 | Familial Mediterranean fever | | | | 281 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MEFV CL E G H | 4210 | 6998 | OMIM:608068 | NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE | | | | 281 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MFAP5 CL E G H | 8076 | 29673 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MMP23B CL E G H | 8510 | 7171 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MPL CL E G H | 4352 | 7217 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 97 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:729 | Polycythemia vera | | | | 97 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | | | | 97 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MRE11 CL E G H | 4361 | 7230 | OMIM:604391 | Ataxia-Telangiectasia-Like disorder 1 | | | | 532 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MTAP CL E G H | 4507 | 7413 | OMIM:112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | | | | 85 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | | | | 150 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYH11 CL E G H | 4629 | 7569 | OMIM:132900 | Aortic aneurysm, familial thoracic 4 | | | | 418 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYH11 CL E G H | 4629 | 7569 | ORPHA:229 | Familial aortic dissection | | | | 418 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYH11 CL E G H | 4629 | 7569 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 418 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYH9 CL E G H | 4627 | 7579 | ORPHA:182050 | MYH9-related disease | | | | 297 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYLK CL E G H | 4638 | 7590 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 326 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYOF CL E G H | 26509 | 3656 | OMIM:619366 | ANGIOEDEMA, HEREDITARY, 7; HAE7 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | MYORG CL E G H | 57462 | 19918 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NAGA CL E G H | 4668 | 7631 | ORPHA:79279 | Alpha-N-acetylgalactosaminidase deficiency type 1 | | | | 47 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | | | | 47 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NAXD CL E G H | 55739 | 25576 | OMIM:618321 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | | | | 127 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NBEAL2 CL E G H | 23218 | 31928 | ORPHA:721 | Gray platelet syndrome | | | | 127 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND2 CL E G H | 4536 | 7456 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND4L CL E G H | 4539 | 7460 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NDP CL E G H | 4693 | 7678 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:104 | Leber hereditary optic neuropathy | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NEU1 CL E G H | 4758 | 7758 | ORPHA:812 | Sialidosis type 1 | HP:0040281 - Very frequent | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NF1 CL E G H | 4763 | 7765 | ORPHA:97685 | 17q11 microdeletion syndrome | | | | 1952 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFIA CL E G H | 4774 | 7784 | ORPHA:401986 | 1p31p32 microdeletion syndrome | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFIA CL E G H | 4774 | 7784 | OMIM:613735 | Brain malformations with or without urinary tract defects | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFIX CL E G H | 4784 | 7788 | ORPHA:561 | Marshall-Smith syndrome | | | | 40 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFIX CL E G H | 4784 | 7788 | OMIM:614753 | Sotos syndrome 2 | | | | 40 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NHP2 CL E G H | 55651 | 14377 | ORPHA:1775 | Dyskeratosis congenita | | | | 27 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NIPBL CL E G H | 25836 | 28862 | ORPHA:199 | Cornelia de Lange syndrome | | | | 494 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NIPBL CL E G H | 25836 | 28862 | OMIM:122470 | Cornelia de Lange syndrome 1 | | | | 494 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRC4 CL E G H | 58484 | 16412 | OMIM:616050 | AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC | | | | 30 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRC4 CL E G H | 58484 | 16412 | OMIM:616115 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4 | | | | 30 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP12 CL E G H | 91662 | 22938 | OMIM:611762 | Familial cold autoinflammatory syndrome 2 | | | | 99 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:1451 | CINCA syndrome | | | | 217 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP3 CL E G H | 114548 | 16400 | OMIM:617772 | Deafness, autosomal dominant 34, with or without inflammation | | | | 217 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP3 CL E G H | 114548 | 16400 | OMIM:120100 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1 | | | | 217 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:47045 | Familial cold urticaria | | | | 217 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:575 | Muckle-Wells syndrome | | | | 217 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NOD2 CL E G H | 64127 | 5331 | ORPHA:90340 | Blau syndrome | | | | 187 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NOP10 CL E G H | 55505 | 14378 | ORPHA:1775 | Dyskeratosis congenita | | | | 17 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NOTCH1 CL E G H | 4851 | 7881 | ORPHA:974 | Adams-Oliver syndrome | | | | 452 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NPM1 CL E G H | 4869 | 7910 | ORPHA:1775 | Dyskeratosis congenita | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NSDHL CL E G H | 50814 | 13398 | OMIM:308050 | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | | | | 84 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NTRK1 CL E G H | 4914 | 8031 | ORPHA:642 | Hereditary sensory and autonomic neuropathy type 4 | | | | 97 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ODC1 CL E G H | 4953 | 8109 | ORPHA:544488 | Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ORAI1 CL E G H | 84876 | 25896 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | | | | 19 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PARN CL E G H | 5073 | 8609 | ORPHA:1775 | Dyskeratosis congenita | | | | 26 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PCNA CL E G H | 5111 | 8729 | OMIM:615919 | Ataxia-Telangiectasia-Like disorder 2 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PCNA CL E G H | 5111 | 8729 | ORPHA:438134 | PCNA-related progressive neurodegenerative photosensitivity syndrome | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDCD10 CL E G H | 11235 | 8761 | ORPHA:221061 | Familial cerebral cavernous malformation | HP:0040283 - Occasional | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:31112 | Dermatofibrosarcoma protuberans | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDGFRB CL E G H | 5159 | 8804 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | 28 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDPN CL E G H | 10630 | 29602 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PDSS1 CL E G H | 23590 | 17759 | OMIM:614651 | Coenzyme Q10 deficiency, primary, 2 | | | | 40 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PEPD CL E G H | 5184 | 8840 | ORPHA:742 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PERP CL E G H | 64065 | 17637 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PEX6 CL E G H | 5190 | 8859 | ORPHA:95433 | Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome | | | | 98 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PGAP2 CL E G H | 27315 | 17893 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PGAP3 CL E G H | 93210 | 23719 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 20 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | | | | 15 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PGM3 CL E G H | 5238 | 8907 | ORPHA:443811 | PGM3-CDG | | | | 15 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGL CL E G H | 9487 | 8966 | ORPHA:3474 | CHIME syndrome | | | | 36 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGL CL E G H | 9487 | 8966 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 36 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGO CL E G H | 84720 | 23215 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 84 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGT CL E G H | 51604 | 14938 | OMIM:615399 | Paroxysmal nocturnal hemoglobinuria 2 | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGV CL E G H | 55650 | 26031 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 57 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGW CL E G H | 284098 | 23213 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIGY CL E G H | 84992 | 28213 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:201 | Cowden syndrome | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:276280 | Hemihyperplasia-multiple lipomatosis syndrome | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:602501 | Megalencephaly-Capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLAU CL E G H | 5328 | 9052 | OMIM:601709 | Quebec platelet disorder | | | | 50 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614878 | Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated | | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLEC CL E G H | 5339 | 9069 | OMIM:131950 | Epidermolysis bullosa simplex, Ogna type | | | | 759 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLG CL E G H | 5340 | 9071 | OMIM:619360 | ANGIOEDEMA, HEREDITARY, 4; HAE4 | | | | 11 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLOD1 CL E G H | 5351 | 9081 | OMIM:225400 | Ehlers-Danlos syndrome, kyphoscoliotic type, 1 | | | | 105 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLOD1 CL E G H | 5351 | 9081 | ORPHA:1900 | Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency | | | | 105 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PLOD3 CL E G H | 8985 | 9083 | OMIM:612394 | Bone fragility with contractures, arterial rupture, and deafness | | | | 5 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLA1 CL E G H | 5422 | 9173 | OMIM:301220 | PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLD1 CL E G H | 5424 | 9175 | OMIM:615381 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | | | | 731 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | | | | 1129 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLH CL E G H | 5429 | 9181 | ORPHA:90342 | Xeroderma pigmentosum variant | | | | 155 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLH CL E G H | 5429 | 9181 | OMIM:278750 | Xeroderma pigmentosum, Variant type | | | | 155 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | | | | 20 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PORCN CL E G H | 64840 | 17652 | OMIM:305600 | Focal dermal hypoplasia | | | | 20 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | | | | 42 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PPP1R15B CL E G H | 84919 | 14951 | OMIM:616817 | Microcephaly, short stature, and impaired glucose metabolism 2 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRDM16 CL E G H | 63976 | 14000 | ORPHA:1606 | 1p36 deletion syndrome | | | | 148 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRDM5 CL E G H | 11107 | 9349 | ORPHA:90354 | Brittle cornea syndrome | | | | 58 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKACG CL E G H | 5568 | 9382 | OMIM:616176 | Bleeding disorder, platelet-type, 19 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKCZ CL E G H | 5590 | 9412 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRKG1 CL E G H | 5592 | 9414 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 41 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PROC CL E G H | 5624 | 9451 | ORPHA:745 | Severe hereditary thrombophilia due to congenital protein C deficiency | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PROC CL E G H | 5624 | 9451 | OMIM:612304 | Thrombophilia due to protein C deficiency, autosomal recessive | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PROS1 CL E G H | 5627 | 9456 | ORPHA:743 | Severe hereditary thrombophilia due to congenital protein S deficiency | | | | 75 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PROS1 CL E G H | 5627 | 9456 | OMIM:614514 | Thrombophilia due to protein S deficiency, autosomal recessive | | | | 75 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PROS1 CL E G H | 5627 | 9456 | OMIM:612336 | Thrombophilia, hereditary, due to protein S deficiency, autosomal | | | | 75 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PSMB8 CL E G H | 5696 | 9545 | OMIM:256040 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms | | | | 20 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PSMG2 CL E G H | 56984 | 24929 | OMIM:619183 | PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTDSS1 CL E G H | 9791 | 9587 | OMIM:151050 | Lenz-Majewski hyperostotic dwarfism | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | | | | 948 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:201 | Cowden syndrome | | | | 948 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:744 | Proteus syndrome | HP:0040281 - Very frequent | | | 948 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTPN11 CL E G H | 5781 | 9644 | OMIM:163950 | Noonan syndrome 1 | | | | 291 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | | | | 53 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | PYCR1 CL E G H | 5831 | 9721 | OMIM:614438 | Cutis laxa, autosomal recessive, type IIIB | | | | 53 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RAC2 CL E G H | 5880 | 9802 | OMIM:618987 | IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RAD21 CL E G H | 5885 | 9811 | ORPHA:199 | Cornelia de Lange syndrome | | | | 25 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RAD21 CL E G H | 5885 | 9811 | OMIM:614701 | Cornelia de Lange syndrome 4 | | | | 25 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RASA1 CL E G H | 5921 | 9871 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040282 - Frequent | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RASA1 CL E G H | 5921 | 9871 | ORPHA:90307 | Parkes Weber syndrome | | | | 88 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RBPJ CL E G H | 3516 | 5724 | ORPHA:974 | Adams-Oliver syndrome | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RECQL4 CL E G H | 9401 | 9949 | ORPHA:221016 | Rothmund-Thomson syndrome type 2 | | | | 445 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RECQL4 CL E G H | 9401 | 9949 | OMIM:268400 | ROTHMUND-THOMSON SYNDROME; RTS | | | | 445 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RERE CL E G H | 473 | 9965 | ORPHA:1606 | 1p36 deletion syndrome | | | | 16 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RIN2 CL E G H | 54453 | 18750 | OMIM:613075 | Macs syndrome | | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RIN2 CL E G H | 54453 | 18750 | ORPHA:217335 | RIN2 syndrome | | | | 43 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 33 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 60 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNF113A CL E G H | 7737 | 12974 | OMIM:300953 | Trichothiodystrophy 5, nonphotosensitive | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNF213 CL E G H | 57674 | 14539 | ORPHA:2573 | Moyamoya disease | | | | 14 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RPS6KA3 CL E G H | 6197 | 10432 | OMIM:303600 | Coffin-Lowry syndrome | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RTEL1 CL E G H | 51750 | 15888 | ORPHA:1775 | Dyskeratosis congenita | | | | 77 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RUNX1 CL E G H | 861 | 10471 | ORPHA:98850 | Aggressive systemic mastocytosis | | | | 181 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | RUNX1 CL E G H | 861 | 10471 | OMIM:601399 | Platelet disorder, familial, with associated myeloid malignancy | | | | 181 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 55 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SCARB2 CL E G H | 950 | 1665 | ORPHA:77259 | Gaucher disease type 1 | | | | 77 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SCN10A CL E G H | 6336 | 10582 | ORPHA:90026 | Primary erythromelalgia | | | | 146 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SCN11A CL E G H | 11280 | 10583 | ORPHA:90026 | Primary erythromelalgia | | | | 19 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SCN9A CL E G H | 6335 | 10597 | ORPHA:90026 | Primary erythromelalgia | | | | 318 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHB CL E G H | 6390 | 10681 | ORPHA:201 | Cowden syndrome | | | | 237 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHB CL E G H | 6390 | 10681 | OMIM:606764 | Gastrointestinal stromal tumor | | | | 237 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHC CL E G H | 6391 | 10682 | ORPHA:201 | Cowden syndrome | | | | 147 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHC CL E G H | 6391 | 10682 | OMIM:606764 | Gastrointestinal stromal tumor | | | | 147 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:100093 | Carcinoid syndrome | | | | 129 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:201 | Cowden syndrome | | | | 129 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SEC23B CL E G H | 10483 | 10702 | ORPHA:201 | Cowden syndrome | | | | 60 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SERPINE1 CL E G H | 5054 | 8583 | ORPHA:465 | Congenital plasminogen activator inhibitor type 1 deficiency | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SERPINF2 CL E G H | 5345 | 9075 | ORPHA:79 | Congenital alpha2-antiplasmin deficiency | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SERPINF2 CL E G H | 5345 | 9075 | OMIM:262850 | Plasmin inhibitor deficiency | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SERPING1 CL E G H | 710 | 1228 | OMIM:106100 | Angioedema, hereditary, 1 | | | | 64 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SERPING1 CL E G H | 710 | 1228 | ORPHA:100050 | Hereditary angioedema type 1 | | | | 64 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SETX CL E G H | 23064 | 445 | OMIM:606002 | Spinocerebellar ataxia, autosomal recessive 1 | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SF3B4 CL E G H | 10262 | 10771 | OMIM:154400 | Acrofacial dysostosis 1, Nager type | | | | 49 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SH2B3 CL E G H | 10019 | 29605 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SKI CL E G H | 6497 | 10896 | ORPHA:1606 | 1p36 deletion syndrome | | | | 150 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC20A2 CL E G H | 6575 | 10947 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC27A4 CL E G H | 10999 | 10998 | OMIM:608649 | ICHTHYOSIS PREMATURITY SYNDROME; IPS | | | | 26 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC29A3 CL E G H | 55315 | 23096 | OMIM:602782 | Histiocytosis-lymphadenopathy plus syndrome | | | | 68 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC2A10 CL E G H | 81031 | 13444 | ORPHA:3342 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC35A1 CL E G H | 10559 | 11021 | OMIM:603585 | Congenital disorder of glycosylation, type IIf | | | | 24 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC35A1 CL E G H | 10559 | 11021 | ORPHA:238459 | SLC35A1-CDG | | | | 24 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC39A13 CL E G H | 91252 | 20859 | OMIM:612350 | Ehlers-Danlos syndrome, spondylodysplastic type, 3 | | | | 24 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC39A13 CL E G H | 91252 | 20859 | ORPHA:157965 | SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome | | | | 24 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC39A4 CL E G H | 55630 | 17129 | ORPHA:37 | Acrodermatitis enteropathica | | | | 55 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | | | | 55 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLC51A CL E G H | 200931 | 29955 | OMIM:619484 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLFN14 CL E G H | 342618 | 32689 | OMIM:616913 | Bleeding disorder, platelet-type, 20 | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLURP1 CL E G H | 57152 | 18746 | ORPHA:87503 | Mal de Meleda | | | | 15 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SLURP1 CL E G H | 57152 | 18746 | OMIM:248300 | Meleda disease | | | | 15 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD2 CL E G H | 4087 | 6768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:284984 | Aneurysm-osteoarthritis syndrome | | | | 260 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 260 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD3 CL E G H | 4088 | 6769 | OMIM:613795 | LOEYS-DIETZ SYNDROME 3; LDS3 | | | | 260 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 504 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 504 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMAD4 CL E G H | 4089 | 6770 | OMIM:175050 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | | | | 504 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMC1A CL E G H | 8243 | 11111 | ORPHA:199 | Cornelia de Lange syndrome | | | | 135 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMC1A CL E G H | 8243 | 11111 | OMIM:300590 | Cornelia de Lange syndrome 2 | | | | 135 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMC3 CL E G H | 9126 | 2468 | ORPHA:199 | Cornelia de Lange syndrome | | | | 91 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SMC3 CL E G H | 9126 | 2468 | OMIM:610759 | Cornelia de Lange syndrome 3 | | | | 91 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SNX10 CL E G H | 29887 | 14974 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SOS1 CL E G H | 6654 | 11187 | OMIM:610733 | Noonan syndrome 4 | | | | 315 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SOX18 CL E G H | 54345 | 11194 | OMIM:607823 | Hypotrichosis-Lymphedema-Telangiectasia syndrome | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SPEN CL E G H | 23013 | 17575 | ORPHA:1606 | 1p36 deletion syndrome | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SPINK5 CL E G H | 11005 | 15464 | OMIM:256500 | Netherton syndrome | | | | 100 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SPINK5 CL E G H | 11005 | 15464 | ORPHA:634 | Netherton syndrome | | | | 100 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SPRED2 CL E G H | 200734 | 17722 | OMIM:619745 | NOONAN SYNDROME 14; NS14 | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SREBF1 CL E G H | 6720 | 11289 | OMIM:619016 | IFAP SYNDROME 2; IFAP2 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SRSF2 CL E G H | 6427 | 10783 | ORPHA:98850 | Aggressive systemic mastocytosis | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SRSF2 CL E G H | 6427 | 10783 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STAG1 CL E G H | 10274 | 11354 | ORPHA:502434 | STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | | | | 110 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STAT3 CL E G H | 6774 | 11364 | OMIM:147060 | Hyper-IgE recurrent infection syndrome | | | | 110 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STIM1 CL E G H | 6786 | 11386 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | | | | 31 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STN1 CL E G H | 79991 | 26200 | OMIM:617341 | Cerebroretinal microangiopathy with calcifications and cysts 2 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STXBP1 CL E G H | 6812 | 11444 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | | | | 237 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SULT2B1 CL E G H | 6820 | 11459 | OMIM:617571 | Ichthyosis, congenital, autosomal recessive 14 | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SUPT16H CL E G H | 11198 | 11465 | OMIM:619480 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TALDO1 CL E G H | 6888 | 11559 | ORPHA:101028 | Transaldolase deficiency | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TALDO1 CL E G H | 6888 | 11559 | OMIM:606003 | Transaldolase deficiency | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | | | | 22 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TCIRG1 CL E G H | 10312 | 11647 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 82 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TERC CL E G H | 7012 | 11727 | ORPHA:1775 | Dyskeratosis congenita | | | | 48 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:1775 | Dyskeratosis congenita | | | | 238 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:98850 | Aggressive systemic mastocytosis | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:729 | Polycythemia vera | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFB2 CL E G H | 7042 | 11768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFB2 CL E G H | 7042 | 11768 | OMIM:614816 | LOEYS-DIETZ SYNDROME 4; LDS4 | | | | 162 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFB3 CL E G H | 7043 | 11769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 85 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFB3 CL E G H | 7043 | 11769 | OMIM:615582 | LOEYS-DIETZ SYNDROME 5; LDS5 | | | | 85 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 239 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:60030 | Loeys-Dietz syndrome | | | | 239 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 253 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:60030 | Loeys-Dietz syndrome | | | | 253 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGM1 CL E G H | 7051 | 11777 | ORPHA:281127 | Acral self-healing collodion baby | | | | 98 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGM5 CL E G H | 9333 | 11781 | ORPHA:263534 | Acral peeling skin syndrome | | | | 44 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TGM5 CL E G H | 9333 | 11781 | OMIM:609796 | Peeling skin syndrome, Acral type | | | | 44 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TINF2 CL E G H | 26277 | 11824 | ORPHA:1775 | Dyskeratosis congenita | | | | 60 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TMC6 CL E G H | 11322 | 18021 | ORPHA:302 | Epidermodysplasia verruciformis | | | | 10 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TMC8 CL E G H | 147138 | 20474 | ORPHA:302 | Epidermodysplasia verruciformis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | | | | 12 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFRSF1A CL E G H | 7132 | 11916 | ORPHA:32960 | Tumor necrosis factor receptor 1 associated periodic syndrome | | | | 131 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFSF11 CL E G H | 8600 | 11926 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 44 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | | | | 71 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNXB CL E G H | 7148 | 11976 | ORPHA:230839 | Classical-like Ehlers-Danlos syndrome type 1 | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TNXB CL E G H | 7148 | 11976 | OMIM:606408 | Ehlers-Danlos syndrome, classic-like | | | | 134 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRAF3IP2 CL E G H | 10758 | 1343 | ORPHA:1334 | Chronic mucocutaneous candidiasis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | | | | 56 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRPM4 CL E G H | 54795 | 17993 | ORPHA:316 | Progressive symmetric erythrokeratodermia | | | | 124 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TRPV3 CL E G H | 162514 | 18084 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | | | | 151 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TSPAN12 CL E G H | 23554 | 21641 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | TYMS CL E G H | 7298 | 12441 | ORPHA:1775 | Dyskeratosis congenita | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | UBE4B CL E G H | 10277 | 12500 | ORPHA:1606 | 1p36 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USB1 CL E G H | 79650 | 25792 | ORPHA:1775 | Dyskeratosis congenita | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USB1 CL E G H | 79650 | 25792 | OMIM:604173 | Poikiloderma with neutropenia | | | | 8 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USF3 CL E G H | 205717 | 30494 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | UVSSA CL E G H | 57654 | 29304 | OMIM:614640 | Uv-Sensitive syndrome 3 | | | | 3 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | VPS53 CL E G H | 55275 | 25608 | OMIM:615851 | Pontocerebellar hypoplasia, type 2E | | | | 26 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | VWF CL E G H | 7450 | 12726 | OMIM:193400 | Von willebrand disease, type 1 | | | | 533 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | VWF CL E G H | 7450 | 12726 | OMIM:613554 | Von willebrand disease, type 2 | | | | 533 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | VWF CL E G H | 7450 | 12726 | OMIM:277480 | Von willebrand disease, type 3 | | | | 533 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 6 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WNT10A CL E G H | 80326 | 13829 | OMIM:257980 | Odontoonychodermal dysplasia | | | | 71 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WNT10A CL E G H | 80326 | 13829 | ORPHA:50944 | Schöpf-Schulz-Passarge syndrome | | | | 71 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WRAP53 CL E G H | 55135 | 25522 | ORPHA:1775 | Dyskeratosis congenita | | | | 40 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | WRN CL E G H | 7486 | 12791 | ORPHA:902 | Werner syndrome | | | | 310 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPA CL E G H | 7507 | 12814 | OMIM:278700 | Xeroderma pigmentosum, complementation group A | | | | 34 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | | | | 86 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPC CL E G H | 7508 | 12816 | OMIM:278720 | Xeroderma pigmentosum, complementation group C | | | | 86 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPNPEP2 CL E G H | 7512 | 12823 | OMIM:300909 | Acquired angioedema | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPNPEP2 CL E G H | 7512 | 12823 | ORPHA:100057 | Renin-angiotensin-aldosterone system-blocker-induced angioedema | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XPR1 CL E G H | 9213 | 12827 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | | | | 4 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:99812 | LIG4 syndrome | | | | 9 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | | | | 1 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZMPSTE24 CL E G H | 10269 | 12877 | ORPHA:740 | Hutchinson-Gilford progeria syndrome | | | | 83 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZMPSTE24 CL E G H | 10269 | 12877 | OMIM:608612 | Mandibuloacral dysplasia with type B lipodystrophy | | | | 83 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZMPSTE24 CL E G H | 10269 | 12877 | OMIM:275210 | Restrictive dermopathy, lethal | | | | 83 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZNF408 CL E G H | 79797 | 20041 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 14 | | |
HP:0011276 | HP:0011276 | Vascular skin abnormality | 0 | ZNF469 CL E G H | 84627 | 23216 | ORPHA:90354 | Brittle cornea syndrome | | | | 397 | | |
HP:0011276 | HP:0011137 | Non-pruritic urticaria | 1 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 415 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 415 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ABCC9 CL E G H | 10060 | 60 | OMIM:619719 | INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS | | | | 254 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ABL1 CL E G H | 25 | 76 | OMIM:617602 | Congenital heart defects and skeletal malformations syndrome | . | | | 51 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | | | | 16 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | ACTA2 CL E G H | 59 | 130 | OMIM:611788 | AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6 | | | | 94 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ACTA2 CL E G H | 59 | 130 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 94 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ACTA2 CL E G H | 59 | 130 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 94 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ACTA2 CL E G H | 59 | 130 | ORPHA:2573 | Moyamoya disease | HP:0040281 - Very frequent | | | 94 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 178 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 178 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | . | | | 22 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | | | | 22 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ADA2 CL E G H | 51816 | 1839 | ORPHA:820 | Sneddon syndrome | HP:0040281 - Very frequent | | | 22 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ADAM17 CL E G H | 6868 | 195 | OMIM:614328 | INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1 | | | | 2 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ADAM17 CL E G H | 6868 | 195 | ORPHA:294023 | Neonatal inflammatory skin and bowel disease | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ADAMTS2 CL E G H | 9509 | 218 | OMIM:225410 | Ehlers-Danlos syndrome, type VII, autosomal recessive | | | | 165 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ADAR CL E G H | 103 | 225 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 116 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ADGRE2 CL E G H | 30817 | 3337 | OMIM:125630 | Dermodistortive urticaria | . | | | 2 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ADGRE2 CL E G H | 30817 | 3337 | OMIM:125630 | Dermodistortive urticaria | | | | 2 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | AEBP1 CL E G H | 165 | 303 | OMIM:618000 | Ehlers-Danlos syndrome, classic-like, 2 | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | AEBP1 CL E G H | 165 | 303 | OMIM:618000 | Ehlers-Danlos syndrome, classic-like, 2 | | | | | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | AGA CL E G H | 175 | 318 | OMIM:208400 | ASPARTYLGLUCOSAMINURIA | | | | 76 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 85 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | AGXT CL E G H | 189 | 341 | OMIM:259900 | Hyperoxaluria, primary, type I | . | | | 260 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:201 | Cowden syndrome | | | | 54 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | AKT3 CL E G H | 10000 | 393 | OMIM:615937 | Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 2 | . | | | 19 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ALDH18A1 CL E G H | 5832 | 9722 | OMIM:219150 | Cutis laxa, autosomal recessive, type IIIA | . | | | 89 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ALDH3A2 CL E G H | 224 | 403 | ORPHA:816 | Sjögren-Larsson syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ALDH3A2 CL E G H | 224 | 403 | ORPHA:816 | Sjögren-Larsson syndrome | HP:0040281 - Very frequent | | | 87 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ALOX12B CL E G H | 242 | 430 | OMIM:242100 | Ichthyosis, congenital, autosomal recessive 2 | HP:0040283 - Occasional | | | 75 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ALOXE3 CL E G H | 59344 | 13743 | OMIM:242100 | Ichthyosis, congenital, autosomal recessive 2 | HP:0040283 - Occasional | | | 63 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ALOXE3 CL E G H | 59344 | 13743 | OMIM:606545 | Ichthyosis, congenital, autosomal recessive 3 | HP:0040283 - Occasional | | | 63 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ALPK1 CL E G H | 80216 | 20917 | OMIM:614979 | Splenomegaly, cytopenia, and vision loss | . | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ANAPC1 CL E G H | 64682 | 19988 | ORPHA:221008 | Rothmund-Thomson syndrome type 1 | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ANAPC1 CL E G H | 64682 | 19988 | ORPHA:221008 | Rothmund-Thomson syndrome type 1 | | | | 2 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | ANGPT1 CL E G H | 284 | 484 | OMIM:619361 | ANGIOEDEMA, HEREDITARY, 5; HAE5 | | | | 5 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ANKRD26 CL E G H | 22852 | 29186 | OMIM:188000 | THROMBOCYTOPENIA 2; THC2 | | | | 106 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ANTXR1 CL E G H | 84168 | 21014 | OMIM:230740 | Gapo syndrome | | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | | | | 49 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | HP:0040281 - Very frequent | | | 49 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | AP1S1 CL E G H | 1174 | 559 | OMIM:609313 | Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma | . | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | AQP5 CL E G H | 362 | 638 | ORPHA:2337 | Non-epidermolytic palmoplantar keratoderma | HP:0040282 - Frequent | | | 5 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ARHGAP31 CL E G H | 57514 | 29216 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 147 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ARHGAP31 CL E G H | 57514 | 29216 | OMIM:100300 | Adams-Oliver syndrome 1 | . | | | 147 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ARID1B CL E G H | 57492 | 18040 | OMIM:135900 | Coffin-Siris syndrome 1 | . | | | 219 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040281 - Very frequent | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | | | | 1 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040281 - Very frequent | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 7 | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | ARPC1B CL E G H | 10095 | 704 | OMIM:617718 | Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ARPC4 CL E G H | 10093 | 707 | OMIM:620141 | | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ARX CL E G H | 170302 | 18060 | ORPHA:94083 | Partington syndrome | | | | 166 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ASXL1 CL E G H | 171023 | 18318 | ORPHA:98850 | Aggressive systemic mastocytosis | HP:0040283 - Occasional | | | 145 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ASXL1 CL E G H | 171023 | 18318 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 145 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ATM CL E G H | 472 | 795 | ORPHA:100 | Ataxia-telangiectasia | | | | 3267 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | | | | 3267 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ATP2C1 CL E G H | 27032 | 13211 | OMIM:169600 | Benign chronic pemphigus | . | | | 56 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ATP2C1 CL E G H | 27032 | 13211 | ORPHA:2841 | Familial benign chronic pemphigus | HP:0040281 - Very frequent | | | 56 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ATP6 CL E G H | 4508 | 7414 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 140 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:2834 | Wrinkly skin syndrome | | | | 140 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 3 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATP7A CL E G H | 538 | 869 | ORPHA:565 | Menkes disease | | | | 192 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATP7A CL E G H | 538 | 869 | OMIM:304150 | Occipital horn syndrome | | | | 192 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATP7A CL E G H | 538 | 869 | ORPHA:198 | Occipital horn syndrome | | | | 192 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | | | | 315 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | ATR CL E G H | 545 | 882 | OMIM:614564 | Cutaneous telangiectasia and cancer syndrome, familial | | | | 168 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ATR CL E G H | 545 | 882 | OMIM:614564 | Cutaneous telangiectasia and cancer syndrome, familial | . | | | 168 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATRX CL E G H | 546 | 886 | ORPHA:231401 | Alpha-thalassemia-myelodysplastic syndrome | | | | 169 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | 169 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | | | | 38 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | BANF1 CL E G H | 8815 | 17397 | OMIM:614008 | Nestor-Guillermo progeria syndrome | | | | 22 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | | | | 101 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | BLM CL E G H | 641 | 1058 | ORPHA:125 | Bloom syndrome | HP:0040283 - Occasional | | | 314 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | BLOC1S3 CL E G H | 388552 | 20914 | OMIM:614077 | Hermansky-Pudlak syndrome 8 | | | | 42 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | BMP2 CL E G H | 650 | 1069 | OMIM:235200 | Hemochromatosis, type 1 | . | | | 13 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | BMPR2 CL E G H | 659 | 1078 | OMIM:178600 | Pulmonary hypertension, primary, 1 | . | | | 525 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | BRAF CL E G H | 673 | 1097 | OMIM:163950 | Noonan syndrome 1 | | | | 276 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | BRD4 CL E G H | 23476 | 13575 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 105 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | C1R CL E G H | 715 | 1246 | OMIM:130080 | Ehlers-Danlos syndrome, periodontal type, 1 | | | | 15 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | C1R CL E G H | 715 | 1246 | OMIM:130080 | Ehlers-Danlos syndrome, periodontal type, 1 | | | | 15 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | C1S CL E G H | 716 | 1247 | OMIM:617174 | Ehlers-Danlos syndrome, periodontal type, 2 | | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | C2 CL E G H | 717 | 1248 | OMIM:217000 | Complement component 2 deficiency | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | C4A CL E G H | 720 | 1323 | OMIM:614380 | Complement component 4A deficiency | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CALR CL E G H | 811 | 1455 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | | | | 1 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | CARMIL2 CL E G H | 146206 | 27089 | OMIM:618131 | IMMUNODEFICIENCY 58; IMD58 | | | | 3 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 87 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 87 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | . | | | 87 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CASZ1 CL E G H | 54897 | 26002 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 11 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 11 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 48 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | CBL CL E G H | 867 | 1541 | ORPHA:98850 | Aggressive systemic mastocytosis | HP:0040283 - Occasional | | | 317 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | CBS CL E G H | 875 | 1550 | ORPHA:394 | Classic homocystinuria | HP:0040283 - Occasional | | | 242 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CBS CL E G H | 875 | 1550 | ORPHA:394 | Classic homocystinuria | HP:0040283 - Occasional | | | 242 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | CBS CL E G H | 875 | 1550 | OMIM:236200 | Homocystinuria due to cystathionine beta-synthase deficiency | . | | | 242 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CCM2 CL E G H | 83605 | 21708 | OMIM:603284 | Cerebral cavernous malformations-2 | . | | | 37 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | | | | 38 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CD28 CL E G H | 940 | 1653 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CD81 CL E G H | 975 | 1701 | OMIM:613496 | Immunodeficiency, common variable, 6 | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:276152 | Multiple endocrine neoplasia type 4 | HP:0040283 - Occasional | | | 102 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CHST14 CL E G H | 113189 | 24464 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 27 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CIB1 CL E G H | 10519 | 16920 | ORPHA:302 | Epidermodysplasia verruciformis | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 102 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CLEC7A CL E G H | 64581 | 14558 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040281 - Very frequent | | | 3 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | COG4 CL E G H | 25839 | 18620 | OMIM:618150 | Saul-Wilson syndrome | | | | 67 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COG8 CL E G H | 84342 | 18623 | ORPHA:95428 | COG8-CDG | | | | 39 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A1 CL E G H | 1277 | 2197 | OMIM:619115 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1 | | | | 373 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:31112 | Dermatofibrosarcoma protuberans | HP:0040281 - Very frequent | | | 373 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A1 CL E G H | 1277 | 2197 | OMIM:130060 | Ehlers-Danlos syndrome, arthrochalasia type, 1 | | | | 373 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A1 CL E G H | 1277 | 2197 | OMIM:166200 | Osteogenesis imperfecta, type I | | | | 373 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A2 CL E G H | 1278 | 2198 | ORPHA:230851 | Cardiac-valvular Ehlers-Danlos syndrome | | | | 243 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A2 CL E G H | 1278 | 2198 | OMIM:619120 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2 | | | | 243 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A2 CL E G H | 1278 | 2198 | OMIM:617821 | Ehlers-Danlos syndrome, arthrochalasia type, 2 | | | | 243 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL1A2 CL E G H | 1278 | 2198 | OMIM:225320 | Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form | | | | 243 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:2500 | Acrogeria | | | | 749 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL3A1 CL E G H | 1281 | 2201 | OMIM:618343 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | | | | 749 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | | | | 749 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | | | | 749 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:158673 | Localized dystrophic epidermolysis bullosa, acral form | HP:0040282 - Frequent | | | 263 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:158673 | Localized dystrophic epidermolysis bullosa, acral form | HP:0040282 - Frequent | | | 263 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 6 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | COX7B CL E G H | 1349 | 2291 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040281 - Very frequent | | | 6 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | CPN1 CL E G H | 1369 | 2312 | OMIM:212070 | Carboxypeptidase N deficiency | . | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CREB3L1 CL E G H | 90993 | 18856 | OMIM:616229 | Osteogenesis imperfecta, type XVI | | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CSTA CL E G H | 1475 | 2481 | ORPHA:263534 | Acral peeling skin syndrome | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CTC1 CL E G H | 80169 | 26169 | OMIM:612199 | Cerebroretinal microangiopathy with calcifications and cysts | | | | 160 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CTC1 CL E G H | 80169 | 26169 | ORPHA:1775 | Dyskeratosis congenita | | | | 160 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | 10 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 10 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 88 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CTSA CL E G H | 5476 | 9251 | OMIM:256540 | Galactosialidosis | | | | 51 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CTSB CL E G H | 1508 | 2527 | ORPHA:50943 | Keratolytic winter erythema | HP:0040281 - Very frequent | | | 1 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | CTSB CL E G H | 1508 | 2527 | OMIM:148370 | Keratolytic winter erythema | . | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CYLD CL E G H | 1540 | 2584 | ORPHA:211 | Familial cylindromatosis | | | | 126 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CYLD CL E G H | 1540 | 2584 | ORPHA:867 | Familial multiple trichoepithelioma | | | | 126 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | CYTB CL E G H | 4519 | 7427 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 30 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 30 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DDB2 CL E G H | 1643 | 2718 | OMIM:278740 | Xeroderma pigmentosum, complementation group E | . | | | 30 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DDR2 CL E G H | 4921 | 2731 | OMIM:618175 | WARBURG-CINOTTI SYNDROME; WRCN | | | | 45 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DDX11 CL E G H | 1663 | 2736 | OMIM:613398 | Warsaw breakage syndrome | . | | | 13 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DHCR7 CL E G H | 1717 | 2860 | ORPHA:818 | Smith-Lemli-Opitz syndrome | HP:0040282 - Frequent | | | 159 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DIAPH1 CL E G H | 1729 | 2876 | ORPHA:2573 | Moyamoya disease | HP:0040281 - Very frequent | | | 118 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DKC1 CL E G H | 1736 | 2890 | ORPHA:1775 | Dyskeratosis congenita | | | | 65 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DLL4 CL E G H | 54567 | 2910 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 9 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DLL4 CL E G H | 54567 | 2910 | OMIM:616589 | Adams-Oliver syndrome 6 | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DNAJC30 CL E G H | 84277 | 16410 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DNAJC30 CL E G H | 84277 | 16410 | OMIM:619382 | LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR | | | | | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | DNASE1L3 CL E G H | 1776 | 2959 | ORPHA:36412 | Hypocomplementemic urticarial vasculitis | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DOCK6 CL E G H | 57572 | 19189 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 18 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | DOCK6 CL E G H | 57572 | 19189 | OMIM:614219 | Adams-Oliver syndrome 2 | . | | | 18 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | DPM1 CL E G H | 8813 | 3005 | OMIM:608799 | Congenital disorder of glycosylation, type IE | . | | | 27 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | DSE CL E G H | 29940 | 21144 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 13 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DSG4 CL E G H | 147409 | 21307 | OMIM:607903 | Hypotrichosis 6 | . | | | 63 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DSP CL E G H | 1832 | 3052 | OMIM:615821 | Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis | . | | | 747 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DSP CL E G H | 1832 | 3052 | OMIM:607655 | Skin fragility-woolly hair syndrome | | | | 747 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | DST CL E G H | 667 | 1090 | OMIM:614653 | Neuropathy, hereditary sensory and autonomic, type VI | | | | 108 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | DTNBP1 CL E G H | 84062 | 17328 | OMIM:614076 | Hermansky-Pudlak syndrome 7 | | | | 46 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | EGFR CL E G H | 1956 | 3236 | ORPHA:294023 | Neonatal inflammatory skin and bowel disease | HP:0040282 - Frequent | | | 257 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ELMO2 CL E G H | 63916 | 17233 | ORPHA:3019 | Ramon syndrome | | | | 3 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | ELN CL E G H | 2006 | 3327 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 172 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ELN CL E G H | 2006 | 3327 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 172 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ELOVL4 CL E G H | 6785 | 14415 | OMIM:614457 | Ichthyosis, spastic quadriplegia, and mental retardation | . | | | 62 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ELOVL4 CL E G H | 6785 | 14415 | ORPHA:1955 | Spinocerebellar ataxia type 34 | HP:0040281 - Very frequent | | | 62 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | EMILIN1 CL E G H | 11117 | 19880 | OMIM:620080 | | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 186 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 186 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 151 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 151 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | EOGT CL E G H | 285203 | 28526 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | EOGT CL E G H | 285203 | 28526 | OMIM:615297 | Adams-Oliver syndrome 4 | HP:0040283 - Occasional | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | EPHB2 CL E G H | 2048 | 3393 | OMIM:618462 | Bleeding disorder, platelet-type, 22 | | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | EPHB4 CL E G H | 2050 | 3395 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | EPHB4 CL E G H | 2050 | 3395 | OMIM:618196 | Capillary malformation-arteriovenous malformation 2 | . | | | 3 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC2 CL E G H | 2068 | 3434 | OMIM:601675 | Trichothiodystrophy 1, photosensitive | . | | | 106 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 106 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 106 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC2 CL E G H | 2068 | 3434 | OMIM:278730 | Xeroderma pigmentosum, complementation group D | . | | | 106 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 106 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 54 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 54 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 54 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 158 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 158 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ERCC4 CL E G H | 2072 | 3436 | OMIM:278760 | Xeroderma pigmentosum, complementation group F | | | | 158 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 158 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 83 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 83 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040281 - Very frequent | | | 83 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | . | | | 199 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:600630 | Uv-Sensitive syndrome 1 | . | | | 199 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F10 CL E G H | 2159 | 3528 | ORPHA:328 | Congenital factor X deficiency | | | | 33 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | F12 CL E G H | 2161 | 3530 | OMIM:610618 | ANGIOEDEMA, HEREDITARY, TYPE III; HAE3 | | | | 28 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F5 CL E G H | 2153 | 3542 | ORPHA:326 | Congenital factor V deficiency | | | | 159 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F5 CL E G H | 2153 | 3542 | OMIM:227400 | Factor V deficiency | | | | 159 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F7 CL E G H | 2155 | 3544 | ORPHA:327 | Congenital factor VII deficiency | | | | 70 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F8 CL E G H | 2157 | 3546 | ORPHA:177926 | Bleeding disorder in hemophilia A carriers without FVIII deficiency | | | | 303 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F8 CL E G H | 2157 | 3546 | OMIM:306700 | Hemophilia A | | | | 303 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F8 CL E G H | 2157 | 3546 | ORPHA:169805 | Moderate hemophilia A | HP:0040282 - Frequent | | | 303 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | F8 CL E G H | 2157 | 3546 | ORPHA:169802 | Severe hemophilia A | | | | 303 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FANCA CL E G H | 2175 | 3582 | OMIM:227650 | Fanconi anemia | | | | 340 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FANCC CL E G H | 2176 | 3584 | OMIM:227645 | Fanconi anemia, complementation group C | | | | 410 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | | | | 147 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FANCE CL E G H | 2178 | 3586 | OMIM:600901 | Fanconi anemia, complementation group E | | | | 73 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | FAS CL E G H | 355 | 11920 | OMIM:601859 | Autoimmune lymphoproliferative syndrome | . | | | 59 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 59 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 59 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 37 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 37 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | FASLG CL E G H | 356 | 11936 | OMIM:601859 | Autoimmune lymphoproliferative syndrome | . | | | 37 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | FBN1 CL E G H | 2200 | 3603 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 1361 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FBN1 CL E G H | 2200 | 3603 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 1361 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FBN1 CL E G H | 2200 | 3603 | OMIM:616914 | Marfan lipodystrophy syndrome | | | | 1361 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | FECH CL E G H | 2235 | 3647 | ORPHA:79278 | Autosomal erythropoietic protoporphyria | HP:0040281 - Very frequent | | | 145 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | FECH CL E G H | 2235 | 3647 | OMIM:177000 | Protoporphyria, erythropoietic, 1 | . | | | 145 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | FERMT1 CL E G H | 55612 | 15889 | ORPHA:2908 | Kindler epidermolysis bullosa | HP:0040281 - Very frequent | | | 136 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | FERMT1 CL E G H | 55612 | 15889 | OMIM:173650 | Kindler syndrome | | | | 136 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FGA CL E G H | 2243 | 3661 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 47 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FGB CL E G H | 2244 | 3662 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 62 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FGG CL E G H | 2266 | 3694 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 34 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FKBP14 CL E G H | 55033 | 18625 | OMIM:614557 | Ehlers-Danlos syndrome, kyphoscoliotic type, 2 | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FKBP14 CL E G H | 55033 | 18625 | ORPHA:300179 | Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FLNA CL E G H | 2316 | 3754 | ORPHA:75497 | X-linked Ehlers-Danlos syndrome | | | | 493 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | FLT4 CL E G H | 2324 | 3767 | OMIM:153100 | Lymphatic malformation 1 | | | | 90 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FOXE3 CL E G H | 2301 | 3808 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 23 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | FOXE3 CL E G H | 2301 | 3808 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 23 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | FOXP3 CL E G H | 50943 | 6106 | ORPHA:37042 | Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | FRG1 CL E G H | 2483 | 3954 | OMIM:158900 | Facioscapulohumeral muscular dystrophy 1 | | | | 1 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | FTO CL E G H | 79068 | 24678 | OMIM:612938 | Growth retardation, developmental delay, coarse facies, and earlydeath | . | | | 70 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | FUCA1 CL E G H | 2517 | 4006 | OMIM:230000 | FUCOSIDOSIS | . | | | 43 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | FZD4 CL E G H | 8322 | 4042 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 109 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | G6PC3 CL E G H | 92579 | 24861 | OMIM:612541 | Neutropenia, severe congenital, 4, autosomal recessive | | | | 37 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GABRD CL E G H | 2563 | 4084 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GATA2 CL E G H | 2624 | 4171 | ORPHA:3226 | Deafness-lymphedema-leukemia syndrome | | | | 137 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:77259 | Gaucher disease type 1 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GDF2 CL E G H | 2658 | 4217 | OMIM:615506 | TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5 | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA1 CL E G H | 2697 | 4274 | ORPHA:1010 | Autosomal dominant palmoplantar keratoderma and congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA1 CL E G H | 2697 | 4274 | ORPHA:317 | Erythrokeratodermia variabilis | HP:0040281 - Very frequent | | | 68 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA1 CL E G H | 2697 | 4274 | OMIM:617525 | Erythrokeratodermia variabilis et progressiva 3 | . | | | 68 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA1 CL E G H | 2697 | 4274 | OMIM:104100 | Palmoplantar keratoderma with congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA5 CL E G H | 2702 | 4279 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 39 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJA8 CL E G H | 2703 | 4281 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 34 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJB3 CL E G H | 2707 | 4285 | ORPHA:317 | Erythrokeratodermia variabilis | HP:0040281 - Very frequent | | | 74 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJB4 CL E G H | 127534 | 4286 | ORPHA:317 | Erythrokeratodermia variabilis | HP:0040281 - Very frequent | | | 12 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GJB4 CL E G H | 127534 | 4286 | OMIM:617524 | Erythrokeratodermia variabilis et progressiva 2 | . | | | 12 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | GLA CL E G H | 2717 | 4296 | OMIM:301500 | Fabry disease | . | | | 291 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | | | | 291 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | HP:0040281 - Very frequent | | | 291 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | GLB1 CL E G H | 2720 | 4298 | OMIM:230500 | GM1-gangliosidosis, type I | | | | 120 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GLUL CL E G H | 2752 | 4341 | OMIM:610015 | GLUTAMINE DEFICIENCY, CONGENITAL | | | | 98 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040281 - Very frequent | | | 16 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040281 - Very frequent | | | 16 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | | | | 16 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | | | | 101 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | | | | 240 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | GSN CL E G H | 2934 | 4620 | ORPHA:85448 | AGel amyloidosis | | | | 53 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | GUCY1A1 CL E G H | 2982 | 4685 | OMIM:615750 | Moyamoya disease 6 with achalasia | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | GUCY1A1 CL E G H | 2982 | 4685 | ORPHA:401945 | Moyamoya disease with early-onset achalasia | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | H4C3 CL E G H | 8364 | 4787 | OMIM:619758 | TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HBA1 CL E G H | 3039 | 4823 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 200 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HBA2 CL E G H | 3040 | 4824 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | | | | 88 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | HCCS CL E G H | 3052 | 4837 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | HDAC8 CL E G H | 55869 | 13315 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | 37 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | HDAC8 CL E G H | 55869 | 13315 | OMIM:300882 | Cornelia de Lange syndrome 5 | | | | 37 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | HEATR3 CL E G H | 55027 | 26087 | OMIM:620072 | | | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | HEY2 CL E G H | 23493 | 4881 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HEY2 CL E G H | 23493 | 4881 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | HFE CL E G H | 3077 | 4886 | OMIM:235200 | Hemochromatosis, type 1 | . | | | 38 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 3 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | HLA-B CL E G H | 3106 | 4932 | ORPHA:36426 | Stevens-Johnson syndrome | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 1 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:703 | Bullous pemphigoid | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:703 | Bullous pemphigoid | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:703 | Bullous pemphigoid | HP:0040281 - Very frequent | | | 2 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:703 | Bullous pemphigoid | HP:0040281 - Very frequent | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | | | | 3 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | HPGD CL E G H | 3248 | 5154 | OMIM:259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive 1 | . | | | 55 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HPS3 CL E G H | 84343 | 15597 | OMIM:614072 | Hermansky-Pudlak syndrome 3 | | | | 67 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | | | | 123 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | | | | 105 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | HS3ST6 CL E G H | 64711 | 14178 | OMIM:619367 | ANGIOEDEMA, HEREDITARY, 8; HAE8 | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 345 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | IARS2 CL E G H | 55699 | 29685 | OMIM:616007 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia | | | | 25 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | IFIH1 CL E G H | 64135 | 18873 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 28 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | IFIH1 CL E G H | 64135 | 18873 | OMIM:615846 | Aicardi-Goutieres syndrome 7 | | | | 28 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IKBKG CL E G H | 8517 | 5961 | ORPHA:464 | Incontinentia pigmenti | HP:0040281 - Very frequent | | | 52 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IKBKG CL E G H | 8517 | 5961 | OMIM:308300 | Incontinentia pigmenti | . | | | 52 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | IKBKG CL E G H | 8517 | 5961 | ORPHA:464 | Incontinentia pigmenti | | | | 52 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IKZF1 CL E G H | 10320 | 13176 | ORPHA:36426 | Stevens-Johnson syndrome | HP:0040281 - Very frequent | | | 8 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:319552 | Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency | HP:0040284 - Very rare | | | 46 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | | | | 46 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IL17F CL E G H | 112744 | 16404 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040281 - Very frequent | | | 14 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IL17RA CL E G H | 23765 | 5985 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040281 - Very frequent | | | 196 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IL17RC CL E G H | 84818 | 18358 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | IL36RN CL E G H | 26525 | 15561 | OMIM:614204 | PSORIASIS 14, PUSTULAR; PSORS14 | | | | 51 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | IL7 CL E G H | 3574 | 6023 | ORPHA:302 | Epidermodysplasia verruciformis | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | IPO8 CL E G H | 10526 | 9853 | ORPHA:60030 | Loeys-Dietz syndrome | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | IPO8 CL E G H | 10526 | 9853 | OMIM:619472 | VISS syndrome | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | IPO8 CL E G H | 10526 | 9853 | OMIM:619472 | VISS syndrome | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | 4 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 119 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 69 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ITGA3 CL E G H | 3675 | 6139 | OMIM:614748 | Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital | . | | | 6 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 80 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | | | | 80 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | JAK2 CL E G H | 3717 | 6192 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 57 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | JAK2 CL E G H | 3717 | 6192 | ORPHA:729 | Polycythemia vera | | | | 57 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | | | | 57 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | JAM2 CL E G H | 58494 | 14686 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | KCNAB2 CL E G H | 8514 | 6229 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KCNQ2 CL E G H | 3785 | 6296 | ORPHA:439218 | KCNQ2-related epileptic encephalopathy | | | | 528 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KDSR CL E G H | 2531 | 4021 | ORPHA:317 | Erythrokeratodermia variabilis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KDSR CL E G H | 2531 | 4021 | OMIM:617526 | Erythrokeratodermia variabilis et progressiva 4 | . | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KDSR CL E G H | 2531 | 4021 | ORPHA:316 | Progressive symmetric erythrokeratodermia | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | KIAA0319L CL E G H | 79932 | 30071 | ORPHA:220402 | Limited cutaneous systemic sclerosis | | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:280785 | Bullous diffuse cutaneous mastocytosis | HP:0040281 - Very frequent | | | 327 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | HP:0040281 - Very frequent | | | 327 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | KIT CL E G H | 3815 | 6342 | OMIM:606764 | Gastrointestinal stromal tumor | . | | | 327 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | KIT CL E G H | 3815 | 6342 | OMIM:154800 | Mastocytosis, cutaneous | . | | | 327 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KIT CL E G H | 3815 | 6342 | OMIM:154800 | Mastocytosis, cutaneous | . | | | 327 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | KIT CL E G H | 3815 | 6342 | OMIM:154800 | Mastocytosis, cutaneous | | | | 327 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | KIT CL E G H | 3815 | 6342 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 327 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | KLLN CL E G H | 100144748 | 37212 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | KNG1 CL E G H | 3827 | 6383 | OMIM:619363 | ANGIOEDEMA, HEREDITARY, 6; HAE6 | | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | KRAS CL E G H | 3845 | 6407 | OMIM:609942 | Noonan syndrome 3 | | | | 196 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT1 CL E G H | 3848 | 6412 | ORPHA:530838 | KRT1-related diffuse nonepidermolytic keratoderma | HP:0040282 - Frequent | | | 100 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT10 CL E G H | 3858 | 6413 | OMIM:607602 | Ichthyosis, cyclic, with epidermolytic hyperkeratosis | . | | | 45 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT14 CL E G H | 3861 | 6416 | ORPHA:79396 | Autosomal dominant generalized epidermolysis bullosa simplex, severe form | HP:0040281 - Very frequent | | | 110 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT2 CL E G H | 3849 | 6439 | ORPHA:455 | Superficial epidermolytic ichthyosis | HP:0040283 - Occasional | | | 67 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT5 CL E G H | 3852 | 6442 | ORPHA:79396 | Autosomal dominant generalized epidermolysis bullosa simplex, severe form | HP:0040281 - Very frequent | | | 173 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT5 CL E G H | 3852 | 6442 | ORPHA:158681 | Epidermolysis bullosa simplex with circinate migratory erythema | | | | 173 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT5 CL E G H | 3852 | 6442 | OMIM:609352 | EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA | | | | 173 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | KRT83 CL E G H | 3889 | 6460 | ORPHA:316 | Progressive symmetric erythrokeratodermia | HP:0040281 - Very frequent | | | 65 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | LARP7 CL E G H | 51574 | 24912 | ORPHA:319671 | Alazami syndrome | HP:0040282 - Frequent | | | 16 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LBR CL E G H | 3930 | 6518 | ORPHA:779 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | LEMD2 CL E G H | 221496 | 21244 | OMIM:619322 | MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS | | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LIG1 CL E G H | 3978 | 6598 | OMIM:619774 | IMMUNODEFICIENCY 96; IMD96 | | | | 9 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LIG4 CL E G H | 3981 | 6601 | OMIM:606593 | Lig4 syndrome | HP:0040284 - Very rare | | | 88 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LIG4 CL E G H | 3981 | 6601 | ORPHA:99812 | LIG4 syndrome | | | | 88 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | LIG4 CL E G H | 3981 | 6601 | ORPHA:99812 | LIG4 syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | LIPN CL E G H | 643418 | 23452 | OMIM:613943 | Ichthyosis, congenital, autosomal recessive 8 | . | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LMAN1 CL E G H | 3998 | 6631 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 56 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | | | | 645 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | | | | 645 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | LMNA CL E G H | 4000 | 6636 | ORPHA:740 | Hutchinson-Gilford progeria syndrome | HP:0040281 - Very frequent | | | 645 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | LMNA CL E G H | 4000 | 6636 | OMIM:151660 | Lipodystrophy, familial partial, type 2 | | | | 645 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LMX1B CL E G H | 4010 | 6654 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | HP:0040283 - Occasional | | | 165 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | LORICRIN CL E G H | 4014 | 6663 | ORPHA:316 | Progressive symmetric erythrokeratodermia | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | LOX CL E G H | 4015 | 6664 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 6 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LOX CL E G H | 4015 | 6664 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 6 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | LRP1 CL E G H | 4035 | 6692 | ORPHA:79100 | Atrophoderma vermiculata | HP:0040283 - Occasional | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | LRP1 CL E G H | 4035 | 6692 | OMIM:604093 | Keratosis pilaris atrophicans | | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LRP5 CL E G H | 4041 | 6697 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 125 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | LSM11 CL E G H | 134353 | 30860 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | LUZP1 CL E G H | 7798 | 14985 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LYST CL E G H | 1130 | 1968 | ORPHA:352723 | Attenuated Chédiak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LYST CL E G H | 1130 | 1968 | ORPHA:167 | Chédiak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | LYST CL E G H | 1130 | 1968 | OMIM:214500 | Chediak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | MANBA CL E G H | 4126 | 6831 | OMIM:248510 | MANNOSIDOSIS, BETA A, LYSOSOMAL | . | | | 55 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MAP2K1 CL E G H | 5604 | 6840 | OMIM:163950 | Noonan syndrome 1 | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MAPK1 CL E G H | 5594 | 6871 | OMIM:619087 | NOONAN SYNDROME 13; NS13 | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | MASP1 CL E G H | 5648 | 6901 | OMIM:257920 | 3mc syndrome 1 | | | | 21 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MAT2A CL E G H | 4144 | 6904 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 13 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MAT2A CL E G H | 4144 | 6904 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 13 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:2273 | Ichthyosis follicularis-alopecia-photophobia syndrome | HP:0040282 - Frequent | | | 22 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:2273 | Ichthyosis follicularis-alopecia-photophobia syndrome | HP:0040283 - Occasional | | | 22 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MBTPS2 CL E G H | 51360 | 15455 | OMIM:308800 | Keratosis follicularis spinulosa decalvans, X-linked | | | | 22 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | HP:0040281 - Very frequent | | | 22 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MCFD2 CL E G H | 90411 | 18451 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 77 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MEFV CL E G H | 4210 | 6998 | ORPHA:342 | Familial Mediterranean fever | HP:0040282 - Frequent | | | 281 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MEFV CL E G H | 4210 | 6998 | OMIM:608068 | NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE | | | | 281 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MFAP5 CL E G H | 8076 | 29673 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 11 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MFAP5 CL E G H | 8076 | 29673 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 11 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | MMP23B CL E G H | 8510 | 7171 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MPL CL E G H | 4352 | 7217 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 97 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MPL CL E G H | 4352 | 7217 | ORPHA:729 | Polycythemia vera | | | | 97 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | | | | 97 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | MRE11 CL E G H | 4361 | 7230 | OMIM:604391 | Ataxia-Telangiectasia-Like disorder 1 | . | | | 532 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MTAP CL E G H | 4507 | 7413 | OMIM:112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | | | | 85 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | | | | 150 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | HP:0040282 - Frequent | | | 150 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | HP:0040283 - Occasional | | | 150 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | | | | 9 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | MYH11 CL E G H | 4629 | 7569 | OMIM:132900 | Aortic aneurysm, familial thoracic 4 | | | | 418 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MYH11 CL E G H | 4629 | 7569 | ORPHA:229 | Familial aortic dissection | HP:0040283 - Occasional | | | 418 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYH11 CL E G H | 4629 | 7569 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 418 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MYH11 CL E G H | 4629 | 7569 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 418 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | | | | 297 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYH9 CL E G H | 4627 | 7579 | ORPHA:182050 | MYH9-related disease | | | | 297 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYLK CL E G H | 4638 | 7590 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 326 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | MYLK CL E G H | 4638 | 7590 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 326 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | MYOF CL E G H | 26509 | 3656 | OMIM:619366 | ANGIOEDEMA, HEREDITARY, 7; HAE7 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | MYORG CL E G H | 57462 | 19918 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NAGA CL E G H | 4668 | 7631 | ORPHA:79279 | Alpha-N-acetylgalactosaminidase deficiency type 1 | HP:0040282 - Frequent | | | 47 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0011276 | HP:0001014 | Angiokeratoma | 1 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | | | | 47 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | | | | 47 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | NAXD CL E G H | 55739 | 25576 | OMIM:618321 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | | | | 127 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NBEAL2 CL E G H | 23218 | 31928 | ORPHA:721 | Gray platelet syndrome | | | | 127 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND2 CL E G H | 4536 | 7456 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND4L CL E G H | 4539 | 7460 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:104 | Leber hereditary optic neuropathy | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NDP CL E G H | 4693 | 7678 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2556 | Microphthalmia with linear skin defects syndrome | HP:0040281 - Very frequent | | | 3 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:104 | Leber hereditary optic neuropathy | | | | 65 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | HP:0040283 - Occasional | | | 43 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NF1 CL E G H | 4763 | 7765 | ORPHA:97685 | 17q11 microdeletion syndrome | | | | 1952 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NFIA CL E G H | 4774 | 7784 | ORPHA:401986 | 1p31p32 microdeletion syndrome | | | | 12 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NFIA CL E G H | 4774 | 7784 | OMIM:613735 | Brain malformations with or without urinary tract defects | . | | | 12 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NFIX CL E G H | 4784 | 7788 | ORPHA:561 | Marshall-Smith syndrome | | | | 40 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NFIX CL E G H | 4784 | 7788 | OMIM:614753 | Sotos syndrome 2 | . | | | 40 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | | | | 11 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NHP2 CL E G H | 55651 | 14377 | ORPHA:1775 | Dyskeratosis congenita | | | | 27 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NIPBL CL E G H | 25836 | 28862 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | 494 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NIPBL CL E G H | 25836 | 28862 | OMIM:122470 | Cornelia de Lange syndrome 1 | . | | | 494 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRC4 CL E G H | 58484 | 16412 | OMIM:616050 | AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC | | | | 30 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRC4 CL E G H | 58484 | 16412 | OMIM:616115 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4 | | | | 30 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP12 CL E G H | 91662 | 22938 | OMIM:611762 | Familial cold autoinflammatory syndrome 2 | | | | 99 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:1451 | CINCA syndrome | HP:0040281 - Very frequent | | | 217 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:1451 | CINCA syndrome | | | | 217 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP3 CL E G H | 114548 | 16400 | OMIM:617772 | Deafness, autosomal dominant 34, with or without inflammation | . | | | 217 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP3 CL E G H | 114548 | 16400 | OMIM:120100 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1 | | | | 217 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:47045 | Familial cold urticaria | HP:0040281 - Very frequent | | | 217 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:47045 | Familial cold urticaria | HP:0040281 - Very frequent | | | 217 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:575 | Muckle-Wells syndrome | HP:0040282 - Frequent | | | 217 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | NOD2 CL E G H | 64127 | 5331 | ORPHA:90340 | Blau syndrome | HP:0040281 - Very frequent | | | 187 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NOP10 CL E G H | 55505 | 14378 | ORPHA:1775 | Dyskeratosis congenita | | | | 17 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NOTCH1 CL E G H | 4851 | 7881 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 452 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | NPM1 CL E G H | 4869 | 7910 | ORPHA:1775 | Dyskeratosis congenita | | | | 12 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | NSDHL CL E G H | 50814 | 13398 | OMIM:308050 | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects | . | | | 34 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NTRK1 CL E G H | 4914 | 8031 | ORPHA:642 | Hereditary sensory and autonomic neuropathy type 4 | | | | 97 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ORAI1 CL E G H | 84876 | 25896 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | | | | 19 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PARN CL E G H | 5073 | 8609 | ORPHA:1775 | Dyskeratosis congenita | | | | 26 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PCNA CL E G H | 5111 | 8729 | OMIM:615919 | Ataxia-Telangiectasia-Like disorder 2 | . | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PCNA CL E G H | 5111 | 8729 | ORPHA:438134 | PCNA-related progressive neurodegenerative photosensitivity syndrome | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | 9 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:31112 | Dermatofibrosarcoma protuberans | HP:0040281 - Very frequent | | | 9 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PDGFRB CL E G H | 5159 | 8804 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | 28 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PDPN CL E G H | 10630 | 29602 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PDSS1 CL E G H | 23590 | 17759 | OMIM:614651 | Coenzyme Q10 deficiency, primary, 2 | . | | | 40 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PEPD CL E G H | 5184 | 8840 | ORPHA:742 | Prolidase deficiency | HP:0040281 - Very frequent | | | 66 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PERP CL E G H | 64065 | 17637 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PEX6 CL E G H | 5190 | 8859 | ORPHA:95433 | Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome | | | | 98 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PGAP2 CL E G H | 27315 | 17893 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PGAP3 CL E G H | 93210 | 23719 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 20 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | | | | 15 | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | . | | | 15 | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | PGM3 CL E G H | 5238 | 8907 | ORPHA:443811 | PGM3-CDG | HP:0040282 - Frequent | | | 15 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PIGL CL E G H | 9487 | 8966 | ORPHA:3474 | CHIME syndrome | HP:0040281 - Very frequent | | | 36 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIGL CL E G H | 9487 | 8966 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 36 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIGO CL E G H | 84720 | 23215 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | PIGT CL E G H | 51604 | 14938 | OMIM:615399 | Paroxysmal nocturnal hemoglobinuria 2 | . | | | 12 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIGV CL E G H | 55650 | 26031 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 57 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIGW CL E G H | 284098 | 23213 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIGY CL E G H | 84992 | 28213 | ORPHA:247262 | Hyperphosphatasia-intellectual disability syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:201 | Cowden syndrome | | | | 162 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:276280 | Hemihyperplasia-multiple lipomatosis syndrome | | | | 162 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | HP:0040282 - Frequent | | | 162 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | | | | 162 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PIK3CA CL E G H | 5290 | 8975 | OMIM:602501 | Megalencephaly-Capillary malformation-polymicrogyria syndrome | . | | | 162 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PLAU CL E G H | 5328 | 9052 | OMIM:601709 | Quebec platelet disorder | | | | 50 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614878 | Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated | . | | | 21 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PLEC CL E G H | 5339 | 9069 | OMIM:131950 | Epidermolysis bullosa simplex, Ogna type | | | | 759 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | PLG CL E G H | 5340 | 9071 | OMIM:619360 | ANGIOEDEMA, HEREDITARY, 4; HAE4 | | | | 11 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PLOD1 CL E G H | 5351 | 9081 | OMIM:225400 | Ehlers-Danlos syndrome, kyphoscoliotic type, 1 | | | | 105 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PLOD1 CL E G H | 5351 | 9081 | ORPHA:1900 | Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency | | | | 105 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PLOD3 CL E G H | 8985 | 9083 | OMIM:612394 | Bone fragility with contractures, arterial rupture, and deafness | | | | 5 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | | | | 3 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | POLA1 CL E G H | 5422 | 9173 | OMIM:301220 | PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | POLD1 CL E G H | 5424 | 9175 | OMIM:615381 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | . | | | 731 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | | | | 1129 | | |
HP:0011276 | HP:0033832 | Livedo | 1 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | | | | 1129 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | POLH CL E G H | 5429 | 9181 | ORPHA:90342 | Xeroderma pigmentosum variant | HP:0040282 - Frequent | | | 155 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | POLH CL E G H | 5429 | 9181 | OMIM:278750 | Xeroderma pigmentosum, Variant type | . | | | 155 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PORCN CL E G H | 64840 | 17652 | OMIM:305600 | Focal dermal hypoplasia | . | | | 20 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | | | | 20 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | HP:0040282 - Frequent | | | 20 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | | | | 42 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | | | | 42 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | | | | 42 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PPP1R15B CL E G H | 84919 | 14951 | OMIM:616817 | Microcephaly, short stature, and impaired glucose metabolism 2 | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PRDM16 CL E G H | 63976 | 14000 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 148 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRDM5 CL E G H | 11107 | 9349 | ORPHA:90354 | Brittle cornea syndrome | | | | 58 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKACG CL E G H | 5568 | 9382 | OMIM:616176 | Bleeding disorder, platelet-type, 19 | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | 10 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PRKCZ CL E G H | 5590 | 9412 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PRKG1 CL E G H | 5592 | 9414 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 41 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRKG1 CL E G H | 5592 | 9414 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 41 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PROC CL E G H | 5624 | 9451 | ORPHA:745 | Severe hereditary thrombophilia due to congenital protein C deficiency | | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PROC CL E G H | 5624 | 9451 | OMIM:612304 | Thrombophilia due to protein C deficiency, autosomal recessive | | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PROS1 CL E G H | 5627 | 9456 | ORPHA:743 | Severe hereditary thrombophilia due to congenital protein S deficiency | HP:0040282 - Frequent | | | 75 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PROS1 CL E G H | 5627 | 9456 | OMIM:614514 | Thrombophilia due to protein S deficiency, autosomal recessive | | | | 75 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PROS1 CL E G H | 5627 | 9456 | OMIM:612336 | Thrombophilia, hereditary, due to protein S deficiency, autosomal | | | | 75 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PSMB8 CL E G H | 5696 | 9545 | OMIM:256040 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms | . | | | 20 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | PSMG2 CL E G H | 56984 | 24929 | OMIM:619183 | PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4 | | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PTDSS1 CL E G H | 9791 | 9587 | OMIM:151050 | Lenz-Majewski hyperostotic dwarfism | . | | | 6 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PTDSS1 CL E G H | 9791 | 9587 | OMIM:151050 | Lenz-Majewski hyperostotic dwarfism | | | | 6 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | HP:0040283 - Occasional | | | 948 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | HP:0040283 - Occasional | | | 948 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:201 | Cowden syndrome | | | | 948 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PTPN11 CL E G H | 5781 | 9644 | OMIM:163950 | Noonan syndrome 1 | | | | 291 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 3 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | | | | 53 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | | | | 53 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | PYCR1 CL E G H | 5831 | 9721 | OMIM:614438 | Cutis laxa, autosomal recessive, type IIIB | | | | 53 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | RAC2 CL E G H | 5880 | 9802 | OMIM:618987 | IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C | | | | 9 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RAD21 CL E G H | 5885 | 9811 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | 25 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RAD21 CL E G H | 5885 | 9811 | OMIM:614701 | Cornelia de Lange syndrome 4 | HP:0040283 - Occasional | | | 25 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | | | | 2 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RASA1 CL E G H | 5921 | 9871 | ORPHA:137667 | Capillary malformation-arteriovenous malformation | HP:0040283 - Occasional | | | 88 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | RASA1 CL E G H | 5921 | 9871 | ORPHA:90307 | Parkes Weber syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RBPJ CL E G H | 3516 | 5724 | ORPHA:974 | Adams-Oliver syndrome | HP:0040281 - Very frequent | | | 3 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | RECQL4 CL E G H | 9401 | 9949 | ORPHA:221016 | Rothmund-Thomson syndrome type 2 | HP:0040281 - Very frequent | | | 445 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RECQL4 CL E G H | 9401 | 9949 | OMIM:268400 | ROTHMUND-THOMSON SYNDROME; RTS | | | | 445 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RERE CL E G H | 473 | 9965 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 16 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RIN2 CL E G H | 54453 | 18750 | OMIM:613075 | Macs syndrome | | | | 43 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RIN2 CL E G H | 54453 | 18750 | ORPHA:217335 | RIN2 syndrome | | | | 43 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RNASEH2A CL E G H | 10535 | 18518 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 33 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RNASEH2B CL E G H | 79621 | 25671 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 34 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RNASEH2C CL E G H | 84153 | 24116 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 60 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RNF113A CL E G H | 7737 | 12974 | OMIM:300953 | Trichothiodystrophy 5, nonphotosensitive | . | | | 3 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RNF213 CL E G H | 57674 | 14539 | ORPHA:2573 | Moyamoya disease | HP:0040281 - Very frequent | | | 14 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RNU7-1 CL E G H | 100147744 | 34033 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | RPS6KA3 CL E G H | 6197 | 10432 | OMIM:303600 | Coffin-Lowry syndrome | . | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | RTEL1 CL E G H | 51750 | 15888 | ORPHA:1775 | Dyskeratosis congenita | | | | 77 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | RUNX1 CL E G H | 861 | 10471 | ORPHA:98850 | Aggressive systemic mastocytosis | HP:0040283 - Occasional | | | 181 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | RUNX1 CL E G H | 861 | 10471 | OMIM:601399 | Platelet disorder, familial, with associated myeloid malignancy | | | | 181 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SAMHD1 CL E G H | 25939 | 15925 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 55 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SCARB2 CL E G H | 950 | 1665 | ORPHA:77259 | Gaucher disease type 1 | | | | 77 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SCN10A CL E G H | 6336 | 10582 | ORPHA:90026 | Primary erythromelalgia | HP:0040281 - Very frequent | | | 146 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SCN11A CL E G H | 11280 | 10583 | ORPHA:90026 | Primary erythromelalgia | HP:0040281 - Very frequent | | | 19 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SCN9A CL E G H | 6335 | 10597 | ORPHA:90026 | Primary erythromelalgia | HP:0040281 - Very frequent | | | 318 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SDHB CL E G H | 6390 | 10681 | ORPHA:201 | Cowden syndrome | | | | 237 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SDHB CL E G H | 6390 | 10681 | OMIM:606764 | Gastrointestinal stromal tumor | . | | | 237 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SDHC CL E G H | 6391 | 10682 | ORPHA:201 | Cowden syndrome | | | | 147 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SDHC CL E G H | 6391 | 10682 | OMIM:606764 | Gastrointestinal stromal tumor | . | | | 147 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:100093 | Carcinoid syndrome | | | | 129 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:201 | Cowden syndrome | | | | 129 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SEC23B CL E G H | 10483 | 10702 | ORPHA:201 | Cowden syndrome | | | | 60 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SERPINE1 CL E G H | 5054 | 8583 | ORPHA:465 | Congenital plasminogen activator inhibitor type 1 deficiency | HP:0040282 - Frequent | | | 39 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SERPINF2 CL E G H | 5345 | 9075 | ORPHA:79 | Congenital alpha2-antiplasmin deficiency | | | | 8 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SERPINF2 CL E G H | 5345 | 9075 | OMIM:262850 | Plasmin inhibitor deficiency | | | | 8 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SERPING1 CL E G H | 710 | 1228 | OMIM:106100 | Angioedema, hereditary, 1 | . | | | 64 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | SERPING1 CL E G H | 710 | 1228 | OMIM:106100 | Angioedema, hereditary, 1 | . | | | 64 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SERPING1 CL E G H | 710 | 1228 | ORPHA:100050 | Hereditary angioedema type 1 | HP:0040281 - Very frequent | | | 64 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SETX CL E G H | 23064 | 445 | OMIM:606002 | Spinocerebellar ataxia, autosomal recessive 1 | | | | 162 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SF3B4 CL E G H | 10262 | 10771 | OMIM:154400 | Acrofacial dysostosis 1, Nager type | . | | | 49 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SH2B3 CL E G H | 10019 | 29605 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SKI CL E G H | 6497 | 10896 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 150 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC20A2 CL E G H | 6575 | 10947 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | 70 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SLC27A4 CL E G H | 10999 | 10998 | OMIM:608649 | ICHTHYOSIS PREMATURITY SYNDROME; IPS | | | | 26 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | | | | 68 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SLC29A3 CL E G H | 55315 | 23096 | OMIM:602782 | Histiocytosis-lymphadenopathy plus syndrome | | | | 68 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SLC2A10 CL E G H | 81031 | 13444 | ORPHA:3342 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC35A1 CL E G H | 10559 | 11021 | OMIM:603585 | Congenital disorder of glycosylation, type IIf | | | | 24 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC35A1 CL E G H | 10559 | 11021 | ORPHA:238459 | SLC35A1-CDG | HP:0040281 - Very frequent | | | 24 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | SLC39A13 CL E G H | 91252 | 20859 | OMIM:612350 | Ehlers-Danlos syndrome, spondylodysplastic type, 3 | | | | 24 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC39A13 CL E G H | 91252 | 20859 | OMIM:612350 | Ehlers-Danlos syndrome, spondylodysplastic type, 3 | | | | 24 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC39A13 CL E G H | 91252 | 20859 | ORPHA:157965 | SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome | | | | 24 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SLC39A4 CL E G H | 55630 | 17129 | ORPHA:37 | Acrodermatitis enteropathica | HP:0040281 - Very frequent | | | 55 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | | | | 55 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLC51A CL E G H | 200931 | 29955 | OMIM:619484 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6 | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SLFN14 CL E G H | 342618 | 32689 | OMIM:616913 | Bleeding disorder, platelet-type, 20 | | | | 6 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SLURP1 CL E G H | 57152 | 18746 | ORPHA:87503 | Mal de Meleda | | | | 15 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SLURP1 CL E G H | 57152 | 18746 | OMIM:248300 | Meleda disease | | | | 15 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD2 CL E G H | 4087 | 6768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 7 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMAD2 CL E G H | 4087 | 6768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:284984 | Aneurysm-osteoarthritis syndrome | | | | 260 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 260 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 260 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD3 CL E G H | 4088 | 6769 | OMIM:613795 | LOEYS-DIETZ SYNDROME 3; LDS3 | | | | 260 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 504 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 504 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 504 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | | | | 504 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SMAD4 CL E G H | 4089 | 6770 | OMIM:175050 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | | | | 504 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMC1A CL E G H | 8243 | 11111 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | 135 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMC1A CL E G H | 8243 | 11111 | OMIM:300590 | Cornelia de Lange syndrome 2 | . | | | 135 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMC3 CL E G H | 9126 | 2468 | ORPHA:199 | Cornelia de Lange syndrome | HP:0040282 - Frequent | | | 91 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SMC3 CL E G H | 9126 | 2468 | OMIM:610759 | Cornelia de Lange syndrome 3 | | | | 91 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SNX10 CL E G H | 29887 | 14974 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SOS1 CL E G H | 6654 | 11187 | OMIM:610733 | Noonan syndrome 4 | | | | 315 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SOX18 CL E G H | 54345 | 11194 | OMIM:607823 | Hypotrichosis-Lymphedema-Telangiectasia syndrome | | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | HP:0040282 - Frequent | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | SPEN CL E G H | 23013 | 17575 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SPINK5 CL E G H | 11005 | 15464 | OMIM:256500 | Netherton syndrome | . | | | 100 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | SPINK5 CL E G H | 11005 | 15464 | OMIM:256500 | Netherton syndrome | . | | | 100 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SPINK5 CL E G H | 11005 | 15464 | ORPHA:634 | Netherton syndrome | HP:0040281 - Very frequent | | | 100 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | SPRED2 CL E G H | 200734 | 17722 | OMIM:619745 | NOONAN SYNDROME 14; NS14 | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SREBF1 CL E G H | 6720 | 11289 | OMIM:619016 | IFAP SYNDROME 2; IFAP2 | | | | 1 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SRSF2 CL E G H | 6427 | 10783 | ORPHA:98850 | Aggressive systemic mastocytosis | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SRSF2 CL E G H | 6427 | 10783 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | STAG1 CL E G H | 10274 | 11354 | ORPHA:502434 | STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | | | | 110 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | STAT3 CL E G H | 6774 | 11364 | OMIM:147060 | Hyper-IgE recurrent infection syndrome | . | | | 110 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | STIM1 CL E G H | 6786 | 11386 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | | | | 31 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0033832 | Livedo | 1 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | STN1 CL E G H | 79991 | 26200 | OMIM:617341 | Cerebroretinal microangiopathy with calcifications and cysts 2 | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | STXBP1 CL E G H | 6812 | 11444 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | HP:0040283 - Occasional | | | 237 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | SULT2B1 CL E G H | 6820 | 11459 | OMIM:617571 | Ichthyosis, congenital, autosomal recessive 14 | . | | | 4 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | SUPT16H CL E G H | 11198 | 11465 | OMIM:619480 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC | | | | | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | SYK CL E G H | 6850 | 11491 | OMIM:619381 | IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82 | | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TALDO1 CL E G H | 6888 | 11559 | OMIM:606003 | Transaldolase deficiency | | | | 34 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TALDO1 CL E G H | 6888 | 11559 | ORPHA:101028 | Transaldolase deficiency | HP:0040282 - Frequent | | | 34 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | | | | 22 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | | | | 32 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TCIRG1 CL E G H | 10312 | 11647 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 82 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TERC CL E G H | 7012 | 11727 | ORPHA:1775 | Dyskeratosis congenita | | | | 48 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:1775 | Dyskeratosis congenita | | | | 238 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:98850 | Aggressive systemic mastocytosis | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:729 | Polycythemia vera | | | | 3 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | | | | 3 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:98849 | Systemic mastocytosis with associated hematologic neoplasm | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | | | | 67 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFB2 CL E G H | 7042 | 11768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 162 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | TGFB2 CL E G H | 7042 | 11768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 162 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFB2 CL E G H | 7042 | 11768 | OMIM:614816 | LOEYS-DIETZ SYNDROME 4; LDS4 | | | | 162 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFB3 CL E G H | 7043 | 11769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 85 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | TGFB3 CL E G H | 7043 | 11769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 85 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFB3 CL E G H | 7043 | 11769 | OMIM:615582 | LOEYS-DIETZ SYNDROME 5; LDS5 | | | | 85 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 239 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 239 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:60030 | Loeys-Dietz syndrome | | | | 239 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | | | | 253 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040281 - Very frequent | | | 253 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:60030 | Loeys-Dietz syndrome | | | | 253 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TGM1 CL E G H | 7051 | 11777 | ORPHA:281127 | Acral self-healing collodion baby | HP:0040281 - Very frequent | | | 98 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TGM5 CL E G H | 9333 | 11781 | ORPHA:263534 | Acral peeling skin syndrome | HP:0040282 - Frequent | | | 44 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TGM5 CL E G H | 9333 | 11781 | OMIM:609796 | Peeling skin syndrome, Acral type | . | | | 44 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TINF2 CL E G H | 26277 | 11824 | ORPHA:1775 | Dyskeratosis congenita | | | | 60 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TMC6 CL E G H | 11322 | 18021 | ORPHA:302 | Epidermodysplasia verruciformis | | | | 10 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TMC8 CL E G H | 147138 | 20474 | ORPHA:302 | Epidermodysplasia verruciformis | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | | | | 12 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNFRSF1A CL E G H | 7132 | 11916 | ORPHA:32960 | Tumor necrosis factor receptor 1 associated periodic syndrome | | | | 131 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TNFRSF1A CL E G H | 7132 | 11916 | ORPHA:32960 | Tumor necrosis factor receptor 1 associated periodic syndrome | HP:0040282 - Frequent | | | 131 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TNFRSF1B CL E G H | 7133 | 11917 | ORPHA:2584 | Classic mycosis fungoides | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNFSF11 CL E G H | 8600 | 11926 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | | | | 44 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | | | | 71 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNXB CL E G H | 7148 | 11976 | ORPHA:230839 | Classical-like Ehlers-Danlos syndrome type 1 | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TNXB CL E G H | 7148 | 11976 | OMIM:606408 | Ehlers-Danlos syndrome, classic-like | | | | 134 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRAF3IP2 CL E G H | 10758 | 1343 | ORPHA:1334 | Chronic mucocutaneous candidiasis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0000965 | Cutis marmorata | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:51 | Aicardi-Goutières syndrome | HP:0040283 - Occasional | | | 56 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | HP:0040283 - Occasional | | | 56 | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | | | | 56 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | . | | | 56 | | |
HP:0011276 | HP:0200029 | Vasculitis in the skin | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | . | | | 56 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRPM4 CL E G H | 54795 | 17993 | ORPHA:316 | Progressive symmetric erythrokeratodermia | HP:0040281 - Very frequent | | | 124 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | TRPV3 CL E G H | 162514 | 18084 | ORPHA:659 | Mutilating palmoplantar keratoderma with periorificial keratotic plaques | HP:0040281 - Very frequent | | | 151 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TSPAN12 CL E G H | 23554 | 21641 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | TYMS CL E G H | 7298 | 12441 | ORPHA:1775 | Dyskeratosis congenita | | | | 1 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | UBE4B CL E G H | 10277 | 12500 | ORPHA:1606 | 1p36 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | | | | | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | USB1 CL E G H | 79650 | 25792 | ORPHA:1775 | Dyskeratosis congenita | | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | USB1 CL E G H | 79650 | 25792 | OMIM:604173 | Poikiloderma with neutropenia | | | | 8 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | USF3 CL E G H | 205717 | 30494 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | UVSSA CL E G H | 57654 | 29304 | OMIM:614640 | Uv-Sensitive syndrome 3 | . | | | 3 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | VPS53 CL E G H | 55275 | 25608 | OMIM:615851 | Pontocerebellar hypoplasia, type 2E | | | | 26 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | VWF CL E G H | 7450 | 12726 | OMIM:193400 | Von willebrand disease, type 1 | | | | 533 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | VWF CL E G H | 7450 | 12726 | OMIM:613554 | Von willebrand disease, type 2 | | | | 533 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | VWF CL E G H | 7450 | 12726 | OMIM:277480 | Von willebrand disease, type 3 | | | | 533 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040283 - Occasional | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 6 | | |
HP:0011276 | HP:0001025 | Urticaria | 1 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | WNT10A CL E G H | 80326 | 13829 | OMIM:257980 | Odontoonychodermal dysplasia | . | | | 71 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | WNT10A CL E G H | 80326 | 13829 | ORPHA:50944 | Schöpf-Schulz-Passarge syndrome | | | | 71 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | WRAP53 CL E G H | 55135 | 25522 | ORPHA:1775 | Dyskeratosis congenita | | | | 40 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | WRN CL E G H | 7486 | 12791 | ORPHA:902 | Werner syndrome | | | | 310 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 34 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 34 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | XPA CL E G H | 7507 | 12814 | OMIM:278700 | Xeroderma pigmentosum, complementation group A | . | | | 34 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | HP:0040282 - Frequent | | | 86 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 86 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | XPC CL E G H | 7508 | 12816 | OMIM:278720 | Xeroderma pigmentosum, complementation group C | . | | | 86 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | XPNPEP2 CL E G H | 7512 | 12823 | OMIM:300909 | Acquired angioedema | . | | | 4 | | |
HP:0011276 | HP:0100665 | Angioedema | 1 | XPNPEP2 CL E G H | 7512 | 12823 | ORPHA:100057 | Renin-angiotensin-aldosterone system-blocker-induced angioedema | | | | 4 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | XPNPEP2 CL E G H | 7512 | 12823 | ORPHA:100057 | Renin-angiotensin-aldosterone system-blocker-induced angioedema | | | | 4 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | XPR1 CL E G H | 9213 | 12827 | ORPHA:1980 | Bilateral striopallidodentate calcinosis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:99812 | LIG4 syndrome | | | | 9 | | |
HP:0011276 | HP:0010783 | Erythema | 1 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:99812 | LIG4 syndrome | HP:0040282 - Frequent | | | 9 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | | | | 1 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ZMPSTE24 CL E G H | 10269 | 12877 | ORPHA:740 | Hutchinson-Gilford progeria syndrome | HP:0040281 - Very frequent | | | 83 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ZMPSTE24 CL E G H | 10269 | 12877 | OMIM:608612 | Mandibuloacral dysplasia with type B lipodystrophy | | | | 83 | | |
HP:0011276 | HP:0007394 | Prominent superficial blood vessels | 1 | ZMPSTE24 CL E G H | 10269 | 12877 | OMIM:275210 | Restrictive dermopathy, lethal | . | | | 83 | | |
HP:0011276 | HP:0001009 | Telangiectasia | 1 | ZNF408 CL E G H | 79797 | 20041 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 14 | | |
HP:0011276 | HP:0001933 | Subcutaneous hemorrhage | 1 | ZNF469 CL E G H | 84627 | 23216 | ORPHA:90354 | Brittle cornea syndrome | | | | 397 | | |
HP:0011276 | HP:0034411 | Angiokeratoma of Mibelli | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0034410 | Angiokeratoma circumscriptum naeviforme | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0031181 | Necrolytic migratory erythema | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0034409 | Fordyce angiokeratoma | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0034408 | Solitary angiokeratoma | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0410133 | Chronic idiopathic urticaria | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0025536 | V-sign | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0033622 | Migratory erythematous plaque | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0025535 | Shawl sign | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0040323 | Erythema of the eyelids | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0033167 | Neutrophilic urticarial dermatosis | 2 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040283 - Occasional | | | 415 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040282 - Frequent | | | 415 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | . | | | 16 | | |
HP:0011276 | HP:0033505 | Livedo reticularis | 2 | ACTA2 CL E G H | 59 | 130 | OMIM:611788 | AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6 | | | | 94 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ACTA2 CL E G H | 59 | 130 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 94 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 178 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040282 - Frequent | | | 178 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 178 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 178 | | |
HP:0011276 | HP:0001232 | Nail bed telangiectasia | 2 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0033260 | Livedo racemosa | 2 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | | | | 22 | | |
HP:0011276 | HP:0033505 | Livedo reticularis | 2 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | | | | 22 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0033260 | Livedo racemosa | 2 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0011276 | HP:0033195 | Perianal erythema | 2 | ADAM17 CL E G H | 6868 | 195 | OMIM:614328 | INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1 | | | | 2 | | |
HP:0011276 | HP:0033194 | Perioral erythema | 2 | ADAM17 CL E G H | 6868 | 195 | OMIM:614328 | INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1 | | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ADAMTS2 CL E G H | 9509 | 218 | OMIM:225410 | Ehlers-Danlos syndrome, type VII, autosomal recessive | . | | | 165 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | ADGRE2 CL E G H | 30817 | 3337 | OMIM:125630 | Dermodistortive urticaria | . | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | AEBP1 CL E G H | 165 | 303 | OMIM:618000 | Ehlers-Danlos syndrome, classic-like, 2 | . | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | AEBP1 CL E G H | 165 | 303 | OMIM:618000 | Ehlers-Danlos syndrome, classic-like, 2 | | | | | | |
HP:0011276 | HP:0001071 | Angiokeratoma corporis diffusum | 2 | AGA CL E G H | 175 | 318 | OMIM:208400 | ASPARTYLGLUCOSAMINURIA | . | | | 76 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | AGPAT2 CL E G H | 10555 | 325 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 85 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | AKT1 CL E G H | 207 | 391 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 54 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | ANAPC1 CL E G H | 64682 | 19988 | ORPHA:221008 | Rothmund-Thomson syndrome type 1 | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ANKRD26 CL E G H | 22852 | 29186 | OMIM:188000 | THROMBOCYTOPENIA 2; THC2 | | | | 106 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ANTXR1 CL E G H | 84168 | 21014 | OMIM:230740 | Gapo syndrome | | | | 8 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | HP:0040281 - Very frequent | | | 49 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | HP:0040282 - Frequent | | | 7 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ARPC4 CL E G H | 10093 | 707 | OMIM:620141 | | | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ARX CL E G H | 170302 | 18060 | ORPHA:94083 | Partington syndrome | | | | 166 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | | | | 3267 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ATM CL E G H | 472 | 795 | ORPHA:100 | Ataxia-telangiectasia | HP:0040281 - Very frequent | | | 3267 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ATM CL E G H | 472 | 795 | ORPHA:100 | Ataxia-telangiectasia | HP:0040281 - Very frequent | | | 3267 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ATP6 CL E G H | 4508 | 7414 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 140 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:2834 | Wrinkly skin syndrome | | | | 140 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 3 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 2 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ATP7A CL E G H | 538 | 869 | ORPHA:565 | Menkes disease | HP:0040283 - Occasional | | | 192 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ATP7A CL E G H | 538 | 869 | OMIM:304150 | Occipital horn syndrome | . | | | 192 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ATP7A CL E G H | 538 | 869 | ORPHA:198 | Occipital horn syndrome | HP:0040282 - Frequent | | | 192 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ATP7B CL E G H | 540 | 870 | ORPHA:905 | Wilson disease | HP:0040281 - Very frequent | | | 315 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ATR CL E G H | 545 | 882 | OMIM:614564 | Cutaneous telangiectasia and cancer syndrome, familial | | | | 168 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ATRX CL E G H | 546 | 886 | ORPHA:231401 | Alpha-thalassemia-myelodysplastic syndrome | HP:0040282 - Frequent | | | 169 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 169 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | 169 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | HP:0040282 - Frequent | | | 38 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | BANF1 CL E G H | 8815 | 17397 | OMIM:614008 | Nestor-Guillermo progeria syndrome | | | | 22 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | BLOC1S3 CL E G H | 388552 | 20914 | OMIM:614077 | Hermansky-Pudlak syndrome 8 | . | | | 42 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | BLOC1S5 CL E G H | 63915 | 18561 | OMIM:619172 | HERMANSKY-PUDLAK SYNDROME 11; HPS11 | | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 276 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | BRAF CL E G H | 673 | 1097 | OMIM:163950 | Noonan syndrome 1 | | | | 276 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 105 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | C1R CL E G H | 715 | 1246 | OMIM:130080 | Ehlers-Danlos syndrome, periodontal type, 1 | . | | | 15 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | C1R CL E G H | 715 | 1246 | OMIM:130080 | Ehlers-Danlos syndrome, periodontal type, 1 | | | | 15 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | C1S CL E G H | 716 | 1247 | OMIM:617174 | Ehlers-Danlos syndrome, periodontal type, 2 | . | | | 7 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | C2 CL E G H | 717 | 1248 | OMIM:217000 | Complement component 2 deficiency | . | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | C4A CL E G H | 720 | 1323 | OMIM:614380 | Complement component 4A deficiency | . | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CALR CL E G H | 811 | 1455 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | CARMIL2 CL E G H | 146206 | 27089 | OMIM:618131 | IMMUNODEFICIENCY 58; IMD58 | | | | 3 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CASP10 CL E G H | 843 | 1500 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040282 - Frequent | | | 87 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | CAV1 CL E G H | 857 | 1527 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 11 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 11 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CAV1 CL E G H | 857 | 1527 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 11 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | CAV1 CL E G H | 857 | 1527 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 11 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | CAVIN1 CL E G H | 284119 | 9688 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 48 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 38 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CD81 CL E G H | 975 | 1701 | OMIM:613496 | Immunodeficiency, common variable, 6 | | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 636 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | . | | | 27 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CHST14 CL E G H | 113189 | 24464 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 27 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CIB1 CL E G H | 10519 | 16920 | ORPHA:302 | Epidermodysplasia verruciformis | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CLCN7 CL E G H | 1186 | 2025 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040283 - Occasional | | | 102 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | COG4 CL E G H | 25839 | 18620 | OMIM:618150 | Saul-Wilson syndrome | . | | | 67 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | COG8 CL E G H | 84342 | 18623 | ORPHA:95428 | COG8-CDG | HP:0040283 - Occasional | | | 39 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 373 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A1 CL E G H | 1277 | 2197 | OMIM:619115 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1 | | | | 373 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A1 CL E G H | 1277 | 2197 | OMIM:130060 | Ehlers-Danlos syndrome, arthrochalasia type, 1 | . | | | 373 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A1 CL E G H | 1277 | 2197 | OMIM:166200 | Osteogenesis imperfecta, type I | . | | | 373 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A2 CL E G H | 1278 | 2198 | ORPHA:230851 | Cardiac-valvular Ehlers-Danlos syndrome | HP:0040282 - Frequent | | | 243 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A2 CL E G H | 1278 | 2198 | OMIM:619120 | COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2 | | | | 243 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A2 CL E G H | 1278 | 2198 | OMIM:617821 | Ehlers-Danlos syndrome, arthrochalasia type, 2 | . | | | 243 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL1A2 CL E G H | 1278 | 2198 | OMIM:225320 | Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form | . | | | 243 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:2500 | Acrogeria | HP:0040282 - Frequent | | | 749 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL3A1 CL E G H | 1281 | 2201 | OMIM:618343 | Polymicrogyria with or without vascular-type ehlers-danlos syndrome | . | | | 749 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 749 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | HP:0040282 - Frequent | | | 749 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 660 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 325 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | COX1 CL E G H | 4512 | 7419 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | COX3 CL E G H | 4514 | 7422 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 10 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | CREB3L1 CL E G H | 90993 | 18856 | OMIM:616229 | Osteogenesis imperfecta, type XVI | | | | 4 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | CTC1 CL E G H | 80169 | 26169 | OMIM:612199 | Cerebroretinal microangiopathy with calcifications and cysts | . | | | 160 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CTC1 CL E G H | 80169 | 26169 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 160 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 10 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 88 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | CTSA CL E G H | 5476 | 9251 | OMIM:256540 | Galactosialidosis | | | | 51 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CYLD CL E G H | 1540 | 2584 | ORPHA:211 | Familial cylindromatosis | HP:0040281 - Very frequent | | | 126 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | CYLD CL E G H | 1540 | 2584 | ORPHA:867 | Familial multiple trichoepithelioma | HP:0040282 - Frequent | | | 126 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | CYTB CL E G H | 4519 | 7427 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 30 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | | | | 30 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | DKC1 CL E G H | 1736 | 2890 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 65 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | DNAJC30 CL E G H | 84277 | 16410 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | DNAJC30 CL E G H | 84277 | 16410 | OMIM:619382 | LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | DSE CL E G H | 29940 | 21144 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 13 | | |
HP:0011276 | HP:0025493 | Palmoplantar erythema | 2 | DSP CL E G H | 1832 | 3052 | OMIM:607655 | Skin fragility-woolly hair syndrome | | | | 747 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | DTNBP1 CL E G H | 84062 | 17328 | OMIM:614076 | Hermansky-Pudlak syndrome 7 | . | | | 46 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ELMO2 CL E G H | 63916 | 17233 | ORPHA:3019 | Ramon syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ELN CL E G H | 2006 | 3327 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 172 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | EMILIN1 CL E G H | 11117 | 19880 | OMIM:620080 | | | | | 2 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 186 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040282 - Frequent | | | 186 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 186 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 186 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0011276 | HP:0001232 | Nail bed telangiectasia | 2 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040282 - Frequent | | | 151 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040283 - Occasional | | | 151 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | | | | 106 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 106 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | | | | 54 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 54 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | | | | 158 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 158 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | | | | 83 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 83 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | . | | | 13 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F10 CL E G H | 2159 | 3528 | ORPHA:328 | Congenital factor X deficiency | HP:0040283 - Occasional | | | 33 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F10 CL E G H | 2159 | 3528 | ORPHA:328 | Congenital factor X deficiency | HP:0040283 - Occasional | | | 33 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | | | | 60 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | . | | | 60 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | . | | | 60 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | | | | 32 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | . | | | 32 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | . | | | 44 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F5 CL E G H | 2153 | 3542 | ORPHA:326 | Congenital factor V deficiency | HP:0040283 - Occasional | | | 159 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F5 CL E G H | 2153 | 3542 | ORPHA:326 | Congenital factor V deficiency | HP:0040283 - Occasional | | | 159 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F5 CL E G H | 2153 | 3542 | OMIM:227400 | Factor V deficiency | . | | | 159 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F7 CL E G H | 2155 | 3544 | ORPHA:327 | Congenital factor VII deficiency | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F8 CL E G H | 2157 | 3546 | ORPHA:177926 | Bleeding disorder in hemophilia A carriers without FVIII deficiency | HP:0040284 - Very rare | | | 303 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F8 CL E G H | 2157 | 3546 | ORPHA:177926 | Bleeding disorder in hemophilia A carriers without FVIII deficiency | HP:0040281 - Very frequent | | | 303 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F8 CL E G H | 2157 | 3546 | OMIM:306700 | Hemophilia A | . | | | 303 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | F8 CL E G H | 2157 | 3546 | ORPHA:169805 | Moderate hemophilia A | HP:0040284 - Very rare | | | 303 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | F8 CL E G H | 2157 | 3546 | ORPHA:169802 | Severe hemophilia A | HP:0040282 - Frequent | | | 303 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FANCA CL E G H | 2175 | 3582 | OMIM:227650 | Fanconi anemia | . | | | 340 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FANCC CL E G H | 2176 | 3584 | OMIM:227645 | Fanconi anemia, complementation group C | . | | | 410 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FANCD2 CL E G H | 2177 | 3585 | OMIM:227646 | Fanconi anemia, complementation group D2 | . | | | 147 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FANCE CL E G H | 2178 | 3586 | OMIM:600901 | Fanconi anemia, complementation group E | . | | | 73 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FAS CL E G H | 355 | 11920 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040282 - Frequent | | | 59 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FASLG CL E G H | 356 | 11936 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040282 - Frequent | | | 37 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FBN1 CL E G H | 2200 | 3603 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 1361 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FBN1 CL E G H | 2200 | 3603 | OMIM:616914 | Marfan lipodystrophy syndrome | | | | 1361 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | FERMT1 CL E G H | 55612 | 15889 | OMIM:173650 | Kindler syndrome | | | | 136 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FGA CL E G H | 2243 | 3661 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 47 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FGB CL E G H | 2244 | 3662 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 62 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FGG CL E G H | 2266 | 3694 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 34 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FKBP14 CL E G H | 55033 | 18625 | OMIM:614557 | Ehlers-Danlos syndrome, kyphoscoliotic type, 2 | HP:0040283 - Occasional | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FKBP14 CL E G H | 55033 | 18625 | ORPHA:300179 | Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency | HP:0040282 - Frequent | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FLNA CL E G H | 2316 | 3754 | ORPHA:75497 | X-linked Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 493 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | FLT4 CL E G H | 2324 | 3767 | OMIM:153100 | Lymphatic malformation 1 | | | | 90 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | FOS CL E G H | 2353 | 3796 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | FOXE3 CL E G H | 2301 | 3808 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 23 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | FRG1 CL E G H | 2483 | 3954 | OMIM:158900 | Facioscapulohumeral muscular dystrophy 1 | . | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | FZD4 CL E G H | 8322 | 4042 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 109 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | G6PC3 CL E G H | 92579 | 24861 | OMIM:612541 | Neutropenia, severe congenital, 4, autosomal recessive | | | | 37 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | . | | | 29 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | . | | | 29 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GATA2 CL E G H | 2624 | 4171 | ORPHA:3226 | Deafness-lymphedema-leukemia syndrome | HP:0040282 - Frequent | | | 137 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GBA1 CL E G H | 2629 | 4177 | ORPHA:77259 | Gaucher disease type 1 | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | . | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 8 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 8 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | . | | | 3 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | . | | | 129 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | GJA1 CL E G H | 2697 | 4274 | ORPHA:1010 | Autosomal dominant palmoplantar keratoderma and congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0025493 | Palmoplantar erythema | 2 | GJA1 CL E G H | 2697 | 4274 | OMIM:104100 | Palmoplantar keratoderma with congenital alopecia | | | | 68 | | |
HP:0011276 | HP:0025493 | Palmoplantar erythema | 2 | GJA5 CL E G H | 2702 | 4279 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 39 | | |
HP:0011276 | HP:0025493 | Palmoplantar erythema | 2 | GJA8 CL E G H | 2703 | 4281 | OMIM:612474 | Chromosome 1q21.1 deletion syndrome, 1.35-mb | | | | 34 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | HP:0040281 - Very frequent | | | 291 | | |
HP:0011276 | HP:0001071 | Angiokeratoma corporis diffusum | 2 | GLA CL E G H | 2717 | 4296 | OMIM:301500 | Fabry disease | | | | 291 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | HP:0040281 - Very frequent | | | 291 | | |
HP:0011276 | HP:0001071 | Angiokeratoma corporis diffusum | 2 | GLB1 CL E G H | 2720 | 4298 | OMIM:230500 | GM1-gangliosidosis, type I | . | | | 120 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040282 - Frequent | | | 16 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040283 - Occasional | | | 16 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | | | | 7 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | . | | | 101 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | HP:0040282 - Frequent | | | 101 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | | | | 240 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 23 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | . | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 23 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | . | | | 24 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040283 - Occasional | | | 21 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 21 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | GSN CL E G H | 2934 | 4620 | ORPHA:85448 | AGel amyloidosis | HP:0040282 - Frequent | | | 53 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HBA1 CL E G H | 3039 | 4823 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | HP:0040282 - Frequent | | | 200 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HBA2 CL E G H | 3040 | 4824 | ORPHA:98791 | Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 | HP:0040282 - Frequent | | | 88 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HEY2 CL E G H | 23493 | 4881 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | . | | | 3 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | . | | | 121 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HPS3 CL E G H | 84343 | 15597 | OMIM:614072 | Hermansky-Pudlak syndrome 3 | . | | | 67 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | . | | | 123 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HPS5 CL E G H | 11234 | 17022 | OMIM:614074 | Hermansky-Pudlak syndrome 5 | . | | | 105 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | . | | | 45 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | IARS2 CL E G H | 55699 | 29685 | OMIM:616007 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia | | | | 25 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | IKBKG CL E G H | 8517 | 5961 | ORPHA:464 | Incontinentia pigmenti | HP:0040281 - Very frequent | | | 52 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | | | | 46 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | IL7 CL E G H | 3574 | 6023 | ORPHA:302 | Epidermodysplasia verruciformis | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | IPO8 CL E G H | 10526 | 9853 | ORPHA:60030 | Loeys-Dietz syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | IPO8 CL E G H | 10526 | 9853 | OMIM:619472 | VISS syndrome | | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | | | | 4 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 119 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 119 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 69 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 69 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 69 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | . | | | 69 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 69 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040282 - Frequent | | | 69 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | . | | | 69 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 80 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 80 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040282 - Frequent | | | 80 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 80 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 80 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ITGB3 CL E G H | 3690 | 6156 | OMIM:619267 | GLANZMANN THROMBASTHENIA 2; GT2 | | | | 80 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | JAK2 CL E G H | 3717 | 6192 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 57 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | JAK2 CL E G H | 3717 | 6192 | ORPHA:729 | Polycythemia vera | HP:0040281 - Very frequent | | | 57 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | KCNQ2 CL E G H | 3785 | 6296 | ORPHA:439218 | KCNQ2-related epileptic encephalopathy | HP:0040282 - Frequent | | | 528 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | KIAA0319L CL E G H | 79932 | 30071 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | KIAA0319L CL E G H | 79932 | 30071 | ORPHA:220402 | Limited cutaneous systemic sclerosis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0007583 | Telangiectasia macularis eruptiva perstans | 2 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0025081 | Darier's sign | 2 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0007583 | Telangiectasia macularis eruptiva perstans | 2 | KIT CL E G H | 3815 | 6342 | OMIM:154800 | Mastocytosis, cutaneous | . | | | 327 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | KLLN CL E G H | 100144748 | 37212 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | KRAS CL E G H | 3845 | 6407 | OMIM:609942 | Noonan syndrome 3 | | | | 196 | | |
HP:0011276 | HP:0031180 | Erythema migrans | 2 | KRT5 CL E G H | 3852 | 6442 | ORPHA:158681 | Epidermolysis bullosa simplex with circinate migratory erythema | HP:0040282 - Frequent | | | 173 | | |
HP:0011276 | HP:0031180 | Erythema migrans | 2 | KRT5 CL E G H | 3852 | 6442 | OMIM:609352 | EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA | | | | 173 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | LBR CL E G H | 3930 | 6518 | ORPHA:779 | Reynolds syndrome | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | LBR CL E G H | 3930 | 6518 | ORPHA:779 | Reynolds syndrome | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | LEMD2 CL E G H | 221496 | 21244 | OMIM:619322 | MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS | | | | 1 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | LIG1 CL E G H | 3978 | 6598 | OMIM:619774 | IMMUNODEFICIENCY 96; IMD96 | | | | 9 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | LIG4 CL E G H | 3981 | 6601 | ORPHA:99812 | LIG4 syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | LMAN1 CL E G H | 3998 | 6631 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | HP:0040282 - Frequent | | | 56 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | HP:0040281 - Very frequent | | | 645 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | LMNA CL E G H | 4000 | 6636 | ORPHA:79474 | Atypical Werner syndrome | HP:0040281 - Very frequent | | | 645 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | LMNA CL E G H | 4000 | 6636 | OMIM:151660 | Lipodystrophy, familial partial, type 2 | . | | | 645 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | LOX CL E G H | 4015 | 6664 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 6 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | LRP5 CL E G H | 4041 | 6697 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 125 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | LYST CL E G H | 1130 | 1968 | ORPHA:352723 | Attenuated Chédiak-Higashi syndrome | HP:0040281 - Very frequent | | | 239 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | LYST CL E G H | 1130 | 1968 | ORPHA:167 | Chédiak-Higashi syndrome | HP:0040282 - Frequent | | | 239 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | LYST CL E G H | 1130 | 1968 | OMIM:214500 | Chediak-Higashi syndrome | | | | 239 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MAP2K1 CL E G H | 5604 | 6840 | OMIM:163950 | Noonan syndrome 1 | | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MAPK1 CL E G H | 5594 | 6871 | OMIM:619087 | NOONAN SYNDROME 13; NS13 | | | | 2 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | MASP1 CL E G H | 5648 | 6901 | OMIM:257920 | 3mc syndrome 1 | | | | 21 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MAT2A CL E G H | 4144 | 6904 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 13 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | MBTPS2 CL E G H | 51360 | 15455 | OMIM:308800 | Keratosis follicularis spinulosa decalvans, X-linked | . | | | 22 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MCFD2 CL E G H | 90411 | 18451 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | HP:0040282 - Frequent | | | 77 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MFAP5 CL E G H | 8076 | 29673 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 11 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | MPL CL E G H | 4352 | 7217 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 97 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MPL CL E G H | 4352 | 7217 | ORPHA:729 | Polycythemia vera | HP:0040281 - Very frequent | | | 97 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MTAP CL E G H | 4507 | 7413 | OMIM:112250 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma | HP:0040283 - Occasional | | | 85 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | HP:0040283 - Occasional | | | 150 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0033505 | Livedo reticularis | 2 | MYH11 CL E G H | 4629 | 7569 | OMIM:132900 | Aortic aneurysm, familial thoracic 4 | | | | 418 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MYH11 CL E G H | 4629 | 7569 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 418 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MYH9 CL E G H | 4627 | 7579 | OMIM:155100 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | . | | | 297 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MYH9 CL E G H | 4627 | 7579 | ORPHA:182050 | MYH9-related disease | HP:0040282 - Frequent | | | 297 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | MYLK CL E G H | 4638 | 7590 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 326 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NAGA CL E G H | 4668 | 7631 | ORPHA:79279 | Alpha-N-acetylgalactosaminidase deficiency type 1 | HP:0040282 - Frequent | | | 47 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | HP:0040281 - Very frequent | | | 47 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0011276 | HP:0001071 | Angiokeratoma corporis diffusum | 2 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | HP:0040281 - Very frequent | | | 47 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | | | | 47 | | |
HP:0011276 | HP:0001071 | Angiokeratoma corporis diffusum | 2 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | . | | | 47 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NBEAL2 CL E G H | 23218 | 31928 | OMIM:139090 | Gray platelet syndrome | . | | | 127 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NBEAL2 CL E G H | 23218 | 31928 | ORPHA:721 | Gray platelet syndrome | HP:0040281 - Very frequent | | | 127 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND1 CL E G H | 4535 | 7455 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND2 CL E G H | 4536 | 7456 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND4 CL E G H | 4538 | 7459 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND4L CL E G H | 4539 | 7460 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND5 CL E G H | 4540 | 7461 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ND6 CL E G H | 4541 | 7462 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | NDP CL E G H | 4693 | 7678 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:104 | Leber hereditary optic neuropathy | HP:0040282 - Frequent | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NF1 CL E G H | 4763 | 7765 | ORPHA:97685 | 17q11 microdeletion syndrome | HP:0040282 - Frequent | | | 1952 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NFIX CL E G H | 4784 | 7788 | ORPHA:561 | Marshall-Smith syndrome | HP:0040282 - Frequent | | | 40 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 7 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 11 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NHP2 CL E G H | 55651 | 14377 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 27 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:1451 | CINCA syndrome | HP:0040283 - Occasional | | | 217 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NOP10 CL E G H | 55505 | 14378 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 17 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | NPM1 CL E G H | 4869 | 7910 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 79 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NTRK1 CL E G H | 4914 | 8031 | ORPHA:642 | Hereditary sensory and autonomic neuropathy type 4 | HP:0040283 - Occasional | | | 97 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000979 | Purpura | 2 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ORAI1 CL E G H | 84876 | 25896 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | HP:0040281 - Very frequent | | | 19 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | PARN CL E G H | 5073 | 8609 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 26 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | PCNA CL E G H | 5111 | 8729 | OMIM:615919 | Ataxia-Telangiectasia-Like disorder 2 | | | | 1 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | PCNA CL E G H | 5111 | 8729 | ORPHA:438134 | PCNA-related progressive neurodegenerative photosensitivity syndrome | HP:0040281 - Very frequent | | | 1 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | PCNA CL E G H | 5111 | 8729 | ORPHA:438134 | PCNA-related progressive neurodegenerative photosensitivity syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0011276 | HP:0007489 | Diffuse telangiectasia | 2 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | . | | | 66 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | PEX6 CL E G H | 5190 | 8859 | ORPHA:95433 | Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome | | | | 98 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 162 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:276280 | Hemihyperplasia-multiple lipomatosis syndrome | HP:0040283 - Occasional | | | 162 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:60040 | Megalencephaly-capillary malformation-polymicrogyria syndrome | HP:0040281 - Very frequent | | | 162 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PLAU CL E G H | 5328 | 9052 | OMIM:601709 | Quebec platelet disorder | . | | | 50 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PLEC CL E G H | 5339 | 9069 | OMIM:131950 | Epidermolysis bullosa simplex, Ogna type | . | | | 759 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PLOD1 CL E G H | 5351 | 9081 | OMIM:225400 | Ehlers-Danlos syndrome, kyphoscoliotic type, 1 | | | | 105 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PLOD1 CL E G H | 5351 | 9081 | ORPHA:1900 | Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency | HP:0040281 - Very frequent | | | 105 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PLOD3 CL E G H | 8985 | 9083 | OMIM:612394 | Bone fragility with contractures, arterial rupture, and deafness | . | | | 5 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | | | | 1129 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | HP:0040281 - Very frequent | | | 20 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PPARG CL E G H | 5468 | 9236 | ORPHA:528 | Congenital generalized lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | . | | | 42 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | | | | 42 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PPP1R15B CL E G H | 84919 | 14951 | OMIM:616817 | Microcephaly, short stature, and impaired glucose metabolism 2 | HP:0040283 - Occasional | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRDM5 CL E G H | 11107 | 9349 | ORPHA:90354 | Brittle cornea syndrome | HP:0040282 - Frequent | | | 58 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 58 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKACA CL E G H | 5566 | 9380 | OMIM:615830 | Pigmented nodular adrenocortical disease, primary, 4 | . | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | PRKACG CL E G H | 5568 | 9382 | OMIM:616176 | Bleeding disorder, platelet-type, 19 | . | | | 2 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKCD CL E G H | 5580 | 9399 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040282 - Frequent | | | 10 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 10 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PRKG1 CL E G H | 5592 | 9414 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 41 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PROC CL E G H | 5624 | 9451 | ORPHA:745 | Severe hereditary thrombophilia due to congenital protein C deficiency | HP:0040282 - Frequent | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PROC CL E G H | 5624 | 9451 | OMIM:612304 | Thrombophilia due to protein C deficiency, autosomal recessive | . | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PROS1 CL E G H | 5627 | 9456 | ORPHA:743 | Severe hereditary thrombophilia due to congenital protein S deficiency | HP:0040281 - Very frequent | | | 75 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PROS1 CL E G H | 5627 | 9456 | OMIM:614514 | Thrombophilia due to protein S deficiency, autosomal recessive | . | | | 75 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PROS1 CL E G H | 5627 | 9456 | OMIM:612336 | Thrombophilia, hereditary, due to protein S deficiency, autosomal | . | | | 75 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PTDSS1 CL E G H | 9791 | 9587 | OMIM:151050 | Lenz-Majewski hyperostotic dwarfism | | | | 6 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | PTEN CL E G H | 5728 | 9588 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PTPN11 CL E G H | 5781 | 9644 | OMIM:163950 | Noonan syndrome 1 | | | | 291 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | | | | 53 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PYCR1 CL E G H | 5831 | 9721 | OMIM:612940 | Cutis laxa, autosomal recessive, type IIB | . | | | 53 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | PYCR1 CL E G H | 5831 | 9721 | OMIM:614438 | Cutis laxa, autosomal recessive, type IIIB | | | | 53 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | RASGRP1 CL E G H | 10125 | 9878 | ORPHA:3261 | Autoimmune lymphoproliferative syndrome | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | RECQL4 CL E G H | 9401 | 9949 | ORPHA:221016 | Rothmund-Thomson syndrome type 2 | HP:0040282 - Frequent | | | 445 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | RHOH CL E G H | 399 | 686 | OMIM:618307 | Epidermodysplasia verruciformis, susceptibility to, 4 | . | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | RIN2 CL E G H | 54453 | 18750 | OMIM:613075 | Macs syndrome | . | | | 43 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | RIN2 CL E G H | 54453 | 18750 | ORPHA:217335 | RIN2 syndrome | HP:0040282 - Frequent | | | 43 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | | | | 7 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | RTEL1 CL E G H | 51750 | 15888 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 77 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | RUNX1 CL E G H | 861 | 10471 | OMIM:601399 | Platelet disorder, familial, with associated myeloid malignancy | . | | | 181 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SCARB2 CL E G H | 950 | 1665 | ORPHA:77259 | Gaucher disease type 1 | HP:0040282 - Frequent | | | 77 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SDHB CL E G H | 6390 | 10681 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 237 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SDHC CL E G H | 6391 | 10682 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 147 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SDHD CL E G H | 6392 | 10683 | ORPHA:100093 | Carcinoid syndrome | | | | 129 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SDHD CL E G H | 6392 | 10683 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 129 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SEC23B CL E G H | 10483 | 10702 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 60 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SERPINF2 CL E G H | 5345 | 9075 | ORPHA:79 | Congenital alpha2-antiplasmin deficiency | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SERPINF2 CL E G H | 5345 | 9075 | OMIM:262850 | Plasmin inhibitor deficiency | . | | | 8 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | SERPING1 CL E G H | 710 | 1228 | ORPHA:100050 | Hereditary angioedema type 1 | | | | 64 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SETX CL E G H | 23064 | 445 | OMIM:606002 | Spinocerebellar ataxia, autosomal recessive 1 | | | | 162 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | SH2B3 CL E G H | 10019 | 29605 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 4 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | . | | | | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | SLC25A24 CL E G H | 29957 | 20662 | OMIM:612289 | Fontaine progeroid syndrome | | | | | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | SLC27A4 CL E G H | 10999 | 10998 | OMIM:608649 | ICHTHYOSIS PREMATURITY SYNDROME; IPS | | | | 26 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | | | | 68 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SLC29A3 CL E G H | 55315 | 23096 | OMIM:602782 | Histiocytosis-lymphadenopathy plus syndrome | | | | 68 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | . | | | 178 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SLC2A10 CL E G H | 81031 | 13444 | ORPHA:3342 | Arterial tortuosity syndrome | HP:0040281 - Very frequent | | | 178 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040283 - Occasional | | | 110 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | SLC39A13 CL E G H | 91252 | 20859 | OMIM:612350 | Ehlers-Danlos syndrome, spondylodysplastic type, 3 | . | | | 24 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLC39A13 CL E G H | 91252 | 20859 | OMIM:612350 | Ehlers-Danlos syndrome, spondylodysplastic type, 3 | . | | | 24 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLC39A13 CL E G H | 91252 | 20859 | ORPHA:157965 | SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome | HP:0040281 - Very frequent | | | 24 | | |
HP:0011276 | HP:0033195 | Perianal erythema | 2 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | | | | 55 | | |
HP:0011276 | HP:0033194 | Perioral erythema | 2 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | | | | 55 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLC51A CL E G H | 200931 | 29955 | OMIM:619484 | CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6 | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SLFN14 CL E G H | 342618 | 32689 | OMIM:616913 | Bleeding disorder, platelet-type, 20 | . | | | 6 | | |
HP:0011276 | HP:0033194 | Perioral erythema | 2 | SLURP1 CL E G H | 57152 | 18746 | OMIM:248300 | Meleda disease | | | | 15 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SMAD2 CL E G H | 4087 | 6768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 7 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:284984 | Aneurysm-osteoarthritis syndrome | HP:0040282 - Frequent | | | 260 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SMAD3 CL E G H | 4088 | 6769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 260 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SMAD3 CL E G H | 4088 | 6769 | OMIM:613795 | LOEYS-DIETZ SYNDROME 3; LDS3 | | | | 260 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 504 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040282 - Frequent | | | 504 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 504 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 504 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040281 - Very frequent | | | 504 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SNX10 CL E G H | 29887 | 14974 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040283 - Occasional | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SOS1 CL E G H | 6654 | 11187 | OMIM:610733 | Noonan syndrome 4 | | | | 315 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SOX18 CL E G H | 54345 | 11194 | OMIM:607823 | Hypotrichosis-Lymphedema-Telangiectasia syndrome | | | | 7 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | SPRED2 CL E G H | 200734 | 17722 | OMIM:619745 | NOONAN SYNDROME 14; NS14 | | | | | | |
HP:0011276 | HP:0033194 | Perioral erythema | 2 | SREBF1 CL E G H | 6720 | 11289 | OMIM:619016 | IFAP SYNDROME 2; IFAP2 | | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | STIM1 CL E G H | 6786 | 11386 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | HP:0040281 - Very frequent | | | 31 | | |
HP:0011276 | HP:0033505 | Livedo reticularis | 2 | STING1 CL E G H | 340061 | 27962 | OMIM:615934 | STING-associated vasculopathy, infantile-onset | | | | | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | STN1 CL E G H | 79991 | 26200 | OMIM:617341 | Cerebroretinal microangiopathy with calcifications and cysts 2 | . | | | 2 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 85 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 70 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | SUPT16H CL E G H | 11198 | 11465 | OMIM:619480 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC | | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | | | | 241 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TCIRG1 CL E G H | 10312 | 11647 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040283 - Occasional | | | 82 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TERC CL E G H | 7012 | 11727 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 48 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 238 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TET2 CL E G H | 54790 | 25941 | ORPHA:729 | Polycythemia vera | HP:0040281 - Very frequent | | | 3 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | . | | | 67 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFB2 CL E G H | 7042 | 11768 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 162 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFB2 CL E G H | 7042 | 11768 | OMIM:614816 | LOEYS-DIETZ SYNDROME 4; LDS4 | | | | 162 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFB3 CL E G H | 7043 | 11769 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 85 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFB3 CL E G H | 7043 | 11769 | OMIM:615582 | LOEYS-DIETZ SYNDROME 5; LDS5 | | | | 85 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 239 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFBR1 CL E G H | 7046 | 11772 | ORPHA:60030 | Loeys-Dietz syndrome | HP:0040283 - Occasional | | | 239 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:91387 | Familial thoracic aortic aneurysm and aortic dissection | HP:0040283 - Occasional | | | 253 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TGFBR2 CL E G H | 7048 | 11773 | ORPHA:60030 | Loeys-Dietz syndrome | HP:0040283 - Occasional | | | 253 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TINF2 CL E G H | 26277 | 11824 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 60 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TMC6 CL E G H | 11322 | 18021 | ORPHA:302 | Epidermodysplasia verruciformis | HP:0040283 - Occasional | | | 10 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TMC8 CL E G H | 147138 | 20474 | ORPHA:302 | Epidermodysplasia verruciformis | HP:0040283 - Occasional | | | 4 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TNFRSF1A CL E G H | 7132 | 11916 | ORPHA:32960 | Tumor necrosis factor receptor 1 associated periodic syndrome | HP:0040283 - Occasional | | | 131 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TNFSF11 CL E G H | 8600 | 11926 | ORPHA:667 | Autosomal recessive malignant osteopetrosis | HP:0040283 - Occasional | | | 44 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0011276 | HP:0410134 | Physical urticaria | 2 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | | | | 71 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TNXB CL E G H | 7148 | 11976 | ORPHA:230839 | Classical-like Ehlers-Danlos syndrome type 1 | HP:0040282 - Frequent | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TNXB CL E G H | 7148 | 11976 | OMIM:606408 | Ehlers-Danlos syndrome, classic-like | . | | | 134 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 911 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | . | | | 56 | | |
HP:0011276 | HP:0200030 | Punctate vasculitis skin lesions | 2 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | HP:0040284 - Very rare | | | 56 | | |
HP:0011276 | HP:0200030 | Punctate vasculitis skin lesions | 2 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | . | | | 56 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | TSPAN12 CL E G H | 23554 | 21641 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 39 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | TYMS CL E G H | 7298 | 12441 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 116 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | USB1 CL E G H | 79650 | 25792 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | USF3 CL E G H | 205717 | 30494 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | HP:0040282 - Frequent | | | 7 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0011276 | HP:0001041 | Facial erythema | 2 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | VPS53 CL E G H | 55275 | 25608 | OMIM:615851 | Pontocerebellar hypoplasia, type 2E | | | | 26 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | VWF CL E G H | 7450 | 12726 | OMIM:193400 | Von willebrand disease, type 1 | | | | 533 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | VWF CL E G H | 7450 | 12726 | OMIM:613554 | Von willebrand disease, type 2 | . | | | 533 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | VWF CL E G H | 7450 | 12726 | OMIM:277480 | Von willebrand disease, type 3 | . | | | 533 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | . | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | . | | | 65 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040281 - Very frequent | | | 65 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 65 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040281 - Very frequent | | | 65 | | |
HP:0011276 | HP:0007420 | Spontaneous hematomas | 2 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040281 - Very frequent | | | 6 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040281 - Very frequent | | | 6 | | |
HP:0011276 | HP:0025493 | Palmoplantar erythema | 2 | WNT10A CL E G H | 80326 | 13829 | OMIM:257980 | Odontoonychodermal dysplasia | | | | 71 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | WNT10A CL E G H | 80326 | 13829 | ORPHA:50944 | Schöpf-Schulz-Passarge syndrome | | | | 71 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | WRAP53 CL E G H | 55135 | 25522 | ORPHA:1775 | Dyskeratosis congenita | HP:0040282 - Frequent | | | 40 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | WRN CL E G H | 7486 | 12791 | ORPHA:902 | Werner syndrome | HP:0040282 - Frequent | | | 310 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | | | | 34 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 34 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 86 | | |
HP:0011276 | HP:0100579 | Mucosal telangiectasiae | 2 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | | | | 86 | | |
HP:0011276 | HP:0100585 | Telangiectasia of the skin | 2 | XRCC4 CL E G H | 7518 | 12831 | ORPHA:99812 | LIG4 syndrome | HP:0040283 - Occasional | | | 9 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0000979 | Purpura | 2 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0001015 | Prominent superficial veins | 2 | ZMPSTE24 CL E G H | 10269 | 12877 | OMIM:608612 | Mandibuloacral dysplasia with type B lipodystrophy | | | | 83 | | |
HP:0011276 | HP:0007763 | Retinal telangiectasia | 2 | ZNF408 CL E G H | 79797 | 20041 | ORPHA:891 | Familial exudative vitreoretinopathy | | | | 14 | | |
HP:0011276 | HP:0000978 | Bruising susceptibility | 2 | ZNF469 CL E G H | 84627 | 23216 | ORPHA:90354 | Brittle cornea syndrome | HP:0040282 - Frequent | | | 397 | | |
HP:0011276 | HP:0410138 | Vibratory urticaria | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0031363 | Palpable purpura | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0009893 | Telangiectasia of the ear | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0410137 | Solar urticaria | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0007586 | Telangiectases producing 'marbled' skin | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0410136 | Aquagenic urticaria | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0025555 | Periungual teleangiectasia | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0100885 | Lateral venous anomaly | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0033370 | Bronchial telangiectasia | 3 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 178 | | |
HP:0011276 | HP:0000228 | Oral cavity telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | | | | 178 | | |
HP:0011276 | HP:0006107 | Fingerpad telangiectases | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0000434 | Nasal mucosa telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0002604 | Gastrointestinal telangiectasia | 3 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | AEBP1 CL E G H | 165 | 303 | ORPHA:536532 | Classical-like Ehlers-Danlos syndrome type 2 | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0011276 | HP:0001043 | Prominent scalp veins | 3 | ANTXR1 CL E G H | 84168 | 21014 | OMIM:230740 | Gapo syndrome | . | | | 8 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | ARPC4 CL E G H | 10093 | 707 | OMIM:620141 | | | | | | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | ARX CL E G H | 170302 | 18060 | ORPHA:94083 | Partington syndrome | HP:0040283 - Occasional | | | 166 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ATM CL E G H | 472 | 795 | OMIM:208900 | ATAXIA-TELANGIECTASIA | . | | | 3267 | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 140 | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:2834 | Wrinkly skin syndrome | HP:0040281 - Very frequent | | | 140 | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 3 | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 2 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | ATR CL E G H | 545 | 882 | OMIM:614564 | Cutaneous telangiectasia and cancer syndrome, familial | | | | 168 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | ATRX CL E G H | 546 | 886 | ORPHA:100075 | Neuroendocrine tumor of stomach | HP:0040284 - Very rare | | | 169 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | | | | 101 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | | | | 314 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | | | | 1 | | |
HP:0011276 | HP:0410135 | Cold urticaria | 3 | CARMIL2 CL E G H | 146206 | 27089 | OMIM:618131 | IMMUNODEFICIENCY 58; IMD58 | | | | 3 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 88 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | CTSA CL E G H | 5476 | 9251 | OMIM:256540 | Galactosialidosis | . | | | 51 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | DAXX CL E G H | 1616 | 2681 | ORPHA:100075 | Neuroendocrine tumor of stomach | HP:0040284 - Very rare | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | DDB2 CL E G H | 1643 | 2718 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 30 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 186 | | |
HP:0011276 | HP:0002604 | Gastrointestinal telangiectasia | 3 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000228 | Oral cavity telangiectasia | 3 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0011276 | HP:0006107 | Fingerpad telangiectases | 3 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000434 | Nasal mucosa telangiectasia | 3 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 106 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 54 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 158 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 83 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | | | | 60 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | | | | 32 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | FZD4 CL E G H | 8322 | 4042 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 109 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | HP:0040281 - Very frequent | | | 291 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | GNAQ CL E G H | 2776 | 4390 | ORPHA:3205 | Sturge-Weber syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | | | | 240 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 23 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 8 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0011276 | HP:0012522 | Spider hemangioma | 3 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0030168 | Dilated superficial abdominal veins | 3 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | GPR35 CL E G H | 2859 | 4492 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | | | | 3 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | 46 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 119 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 69 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 80 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | | | | 80 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | | | | 57 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | . | | | 70 | | |
HP:0011276 | HP:0000228 | Oral cavity telangiectasia | 3 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | | | | 70 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | LIG1 CL E G H | 3978 | 6598 | OMIM:619774 | IMMUNODEFICIENCY 96; IMD96 | | | | 9 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | LRP5 CL E G H | 4041 | 6697 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 125 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | MASP1 CL E G H | 5648 | 6901 | OMIM:257920 | 3mc syndrome 1 | . | | | 21 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | | | | 97 | | |
HP:0011276 | HP:0030168 | Dilated superficial abdominal veins | 3 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0012522 | Spider hemangioma | 3 | MST1 CL E G H | 4485 | 7380 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0000228 | Oral cavity telangiectasia | 3 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0011276 | HP:0000228 | Oral cavity telangiectasia | 3 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | | | | 47 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | NDP CL E G H | 4693 | 7678 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 39 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | PCNA CL E G H | 5111 | 8729 | OMIM:615919 | Ataxia-Telangiectasia-Like disorder 2 | . | | | 1 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | PEX6 CL E G H | 5190 | 8859 | ORPHA:95433 | Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome | HP:0040282 - Frequent | | | 98 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0410135 | Cold urticaria | 3 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | | | | 3 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | | | | 1129 | | |
HP:0011276 | HP:0001043 | Prominent scalp veins | 3 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | HP:0040281 - Very frequent | | | 138 | | |
HP:0011276 | HP:0001043 | Prominent scalp veins | 3 | POLR3A CL E G H | 11128 | 30074 | OMIM:264090 | Wiedemann-Rautenstrauch syndrome | . | | | 138 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0007457 | Prominent veins on trunk | 3 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | HP:0040284 - Very rare | | | 42 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | | | | 134 | | |
HP:0011276 | HP:0001043 | Prominent scalp veins | 3 | PTDSS1 CL E G H | 9791 | 9587 | OMIM:151050 | Lenz-Majewski hyperostotic dwarfism | . | | | 6 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | | | | 2 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | SDHD CL E G H | 6392 | 10683 | ORPHA:100093 | Carcinoid syndrome | HP:0040283 - Occasional | | | 129 | | |
HP:0011276 | HP:0012522 | Spider hemangioma | 3 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0030168 | Dilated superficial abdominal veins | 3 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | SEMA4D CL E G H | 10507 | 10732 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | SERPING1 CL E G H | 710 | 1228 | ORPHA:100050 | Hereditary angioedema type 1 | HP:0040281 - Very frequent | | | 64 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | SETX CL E G H | 23064 | 445 | OMIM:606002 | Spinocerebellar ataxia, autosomal recessive 1 | HP:0040283 - Occasional | | | 162 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | SLC27A4 CL E G H | 10999 | 10998 | OMIM:608649 | ICHTHYOSIS PREMATURITY SYNDROME; IPS | | | | 26 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | SLC29A3 CL E G H | 55315 | 23096 | ORPHA:168569 | H syndrome | HP:0040283 - Occasional | | | 68 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | SLC29A3 CL E G H | 55315 | 23096 | OMIM:602782 | Histiocytosis-lymphadenopathy plus syndrome | | | | 68 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | | | | 178 | | |
HP:0011276 | HP:0012522 | Spider hemangioma | 3 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | . | | | 110 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 504 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | SOX18 CL E G H | 54345 | 11194 | OMIM:607823 | Hypotrichosis-Lymphedema-Telangiectasia syndrome | . | | | 7 | | |
HP:0011276 | HP:0007621 | Telangiectasia of extensor surfaces | 3 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | . | | | 7 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | HP:0040281 - Very frequent | | | 7 | | |
HP:0011276 | HP:0100870 | Plantar telangiectasia | 3 | SOX18 CL E G H | 54345 | 11194 | ORPHA:69735 | Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome | HP:0040281 - Very frequent | | | 7 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | | | | 7 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | | | | 110 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | SUPT16H CL E G H | 11198 | 11465 | OMIM:619480 | NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC | | | | | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | | | | 22 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0100869 | Palmar telangiectasia | 3 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 241 | | |
HP:0011276 | HP:0012522 | Spider hemangioma | 3 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 241 | | |
HP:0011276 | HP:0030168 | Dilated superficial abdominal veins | 3 | TCF4 CL E G H | 6925 | 11634 | ORPHA:171 | Primary sclerosing cholangitis | HP:0040282 - Frequent | | | 241 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | | | | 3 | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | | | |
HP:0011276 | HP:0011971 | Dermatographic urticaria | 3 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | HP:0040281 - Very frequent | | | 71 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | TSPAN12 CL E G H | 23554 | 21641 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 39 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | VPS53 CL E G H | 55275 | 25608 | OMIM:615851 | Pontocerebellar hypoplasia, type 2E | | | | 26 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 6 | | |
HP:0011276 | HP:0007380 | Facial telangiectasia | 3 | WNT10A CL E G H | 80326 | 13829 | ORPHA:50944 | Schöpf-Schulz-Passarge syndrome | HP:0040281 - Very frequent | | | 71 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | XPA CL E G H | 7507 | 12814 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 34 | | |
HP:0011276 | HP:0000524 | Conjunctival telangiectasia | 3 | XPC CL E G H | 7508 | 12816 | ORPHA:910 | Xeroderma pigmentosum | HP:0040281 - Very frequent | | | 86 | | |
HP:0011276 | HP:0031365 | Macular purpura | 3 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | | | | 1 | | |
HP:0011276 | HP:0030503 | Macular telangiectasia | 3 | ZNF408 CL E G H | 79797 | 20041 | ORPHA:891 | Familial exudative vitreoretinopathy | HP:0040283 - Occasional | | | 14 | | |
HP:0011276 | HP:0025203 | Caput medusae | 4 | CL E G H | | | | | | | | | | |
HP:0011276 | HP:0000214 | Lip telangiectasia | 4 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0002707 | Palate telangiectasia | 4 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0000227 | Tongue telangiectasia | 4 | ACVRL1 CL E G H | 94 | 175 | OMIM:600376 | Telangiectasia, hereditary hemorrhagic, type 2 | . | | | 178 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | HP:0040281 - Very frequent | | | 39 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0011276 | HP:0005598 | Facial telangiectasia in butterfly midface distribution | 4 | BLM CL E G H | 641 | 1058 | OMIM:210900 | Bloom syndrome | . | | | 314 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | . | | | 27 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | . | | | 102 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 373 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 660 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 325 | | |
HP:0011276 | HP:0000214 | Lip telangiectasia | 4 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0002707 | Palate telangiectasia | 4 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000227 | Tongue telangiectasia | 4 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | . | | | 186 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | . | | | 42 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | HP:0040282 - Frequent | | | 42 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | . | | | 13 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040283 - Occasional | | | 60 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | . | | | 60 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | . | | | 32 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | . | | | 44 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | . | | | 23 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | . | | | 29 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | . | | | 29 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | . | | | | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | HP:0040284 - Very rare | | | | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | . | | | 3 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | . | | | 3 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | . | | | 129 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | HP:0040283 - Occasional | | | | | |
HP:0011276 | HP:0007421 | Telangiectases of the cheeks | 4 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | HP:0040283 - Occasional | | | 240 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 23 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | . | | | 23 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | . | | | 23 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 23 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 23 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 8 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 8 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | . | | | 24 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 21 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | . | | | 3 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 23 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 119 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 119 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | . | | | 69 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 69 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 69 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 69 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 80 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 80 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 80 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0011276 | HP:0000214 | Lip telangiectasia | 4 | LBR CL E G H | 3930 | 6518 | OMIM:613471 | Reynolds syndrome | . | | | 70 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000214 | Lip telangiectasia | 4 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | HP:0040281 - Very frequent | | | 47 | | |
HP:0011276 | HP:0007428 | Telangiectasia of the oral mucosa | 4 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | HP:0040281 - Very frequent | | | 47 | | |
HP:0011276 | HP:0000214 | Lip telangiectasia | 4 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | . | | | 47 | | |
HP:0011276 | HP:0007428 | Telangiectasia of the oral mucosa | 4 | NAGA CL E G H | 4668 | 7631 | OMIM:609242 | Kanzaki disease | . | | | 47 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | HP:0040283 - Occasional | | | 43 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | . | | | 23 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | . | | | 5 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0011276 | HP:0007421 | Telangiectases of the cheeks | 4 | POLE CL E G H | 5426 | 9177 | OMIM:615139 | Facial dysmorphism, immunodeficiency, livedo, and short stature | . | | | 1129 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 58 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | HP:0040283 - Occasional | | | 67 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | . | | | 8 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 26 | | |
HP:0011276 | HP:0007421 | Telangiectases of the cheeks | 4 | SLC2A10 CL E G H | 81031 | 13444 | OMIM:208050 | Arterial tortuosity syndrome | . | | | 178 | | |
HP:0011276 | HP:0005598 | Facial telangiectasia in butterfly midface distribution | 4 | SOX18 CL E G H | 54345 | 11194 | OMIM:137940 | Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome | . | | | 7 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 48 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 238 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | . | | | 2 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | . | | | 65 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 65 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | . | | | 65 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0011276 | HP:0000967 | Petechiae | 4 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |
HP:0011276 | HP:0031364 | Ecchymosis | 4 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |